The Texas Medical Center Library

DigitalCommons@TMC
The University of Texas MD Anderson Cancer
Center UTHealth Graduate School of
Biomedical Sciences Dissertations and Theses
(Open Access)

The University of Texas MD Anderson Cancer
Center UTHealth Graduate School of
Biomedical Sciences

12-2018

HEME PEROXIDASE HPX-2 PROTECTS CAENORHABDITIS
ELEGANS FROM PATHOGENS
Yi Liu

Follow this and additional works at: https://digitalcommons.library.tmc.edu/utgsbs_dissertations
Part of the Medicine and Health Sciences Commons

Recommended Citation
Liu, Yi, "HEME PEROXIDASE HPX-2 PROTECTS CAENORHABDITIS ELEGANS FROM PATHOGENS" (2018).
The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences
Dissertations and Theses (Open Access). 918.
https://digitalcommons.library.tmc.edu/utgsbs_dissertations/918

This Dissertation (PhD) is brought to you for free and
open access by the The University of Texas MD Anderson
Cancer Center UTHealth Graduate School of Biomedical
Sciences at DigitalCommons@TMC. It has been
accepted for inclusion in The University of Texas MD
Anderson Cancer Center UTHealth Graduate School of
Biomedical Sciences Dissertations and Theses (Open
Access) by an authorized administrator of
DigitalCommons@TMC. For more information, please
contact digitalcommons@library.tmc.edu.

HEME PEROXIDASE HPX-2 PROTECTS CAENORHABDITIS ELEGANS FROM
PATHOGENS

By
Yi Liu, M.S.
APPROVED:
_________________________
Danielle A. Garsin, Ph.D.
Advisory Professor,
_________________________
Ambro van Hoof, Ph.D.
_________________________
Swathi Arur, Ph.D.
_________________________
Hung Ton-that, Ph.D.
_________________________
Kevin Morano, Ph.D.

APPROVED:
_________________________
Dean, The University of Texas
MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences

i

HEME PEROXIDASE HPX-2 PROTECTS CAENORHABDITIS ELEGANS FROM
PATHOGENS

A
DISSERTATION
Presented to the Faculty of
The University of Texas
MD Anderson Cancer Center UTHealth
Graduate School of Biomedical Science
In Partial Fulfillment
of the Requirements
for the Degree of

DOCTOR OF PHILOSOPHY

by
Yi Liu, M.S.
Houston, Texas
December 2018

ii

Dedication
To the memory of my father, Tiehui Liu, who always believed in me.

iii

Acknowledgments
First, I would like to express my sincere gratitude to my mentor, Dr. Danielle Garsin, for
her complete support and guidance. Dr. Garsin is most patient and sympathetic mentor I have
ever had. She gave me the freedom and flexibility to explore my projects and offered
tremendous help when needed. Her passion for science and her kindness for her trainees have
inspired me to a become a better person not only in the scientific area but also in everyday life. I
am lucky to be her student.
Second, I want to thank my advisory committee members, Drs. Kevin Morano, Ambro
van Hoof, Hung ton-that, and Swathi Arur, for their guidance and feedback that helped me
navigate through my project. I would especially like to thank Dr. Ambro van Hoof for his
guidance and valuable insight for my RNAseq project. I would also like to thank Dr. David
Reiner and his lab for their expert advice in worm biology.
Next, I would like to thank my current and past members of the Garsin Lab for their help
and support. Specifically, Ms. Melissa Cruz, Dr. Karan Kaval and Dr. Ozgur Karakuzu for their
help on my project. Dr. Clara Sinel for being a great lunch buddy and a good friend that always
listens. Dr. Carrie Graham for the best companionship through the ups and downs during the
graduate life. They have made the lab an amazingly collaborative and fun space to work in, an
environment I will surely miss.
Last but not least, I would like to thank my family: my father, whose work ethic inspired
me to push forward; my mother who raised me as an independent woman and provided me with
unconditional support for all the decisions I have made throughout life; and my beloved husband
and best friend, Ernie Lai, for his encouragement and comfort during difficult times. I could not
complete this journey without them.

iv

Heme Peroxidase HPX-2 Protects Caenorhabditis elegans from Pathogens
Yi Liu, M.S.
Advisory Professor: Danielle A. Garsin, Ph.D.
Heme-containing peroxidases are important components of innate immunity. Many of
them functionally associate with NADPH oxidase (NOX)/dual oxidase (DUOX) enzymes by
using the hydrogen peroxide they generate in downstream reactions. In Caenorhabditis
elegans, a ShkT-containing peroxidase, SKPO-1, and the dual oxidase, BLI-3, contribute to
resistance against the human pathogen Enterococcus faecalis, likely functioning in conjunction
with each other. However, the exact mechanism(s) by which peroxidases and NOX/DUOXs
contribute to pathogen resistance remain unclear. Here, we demonstrated that another
peroxidase, HPX-2 (Heme-PeroXidase 2), is required for resistance against some, but not all
pathogens. Tissue specific RNA interference (RNAi) revealed that HPX-2 functionally localizes
to the hypodermis of the worm. In congruence with this observation, hpx-2 mutant animals
possessed a slightly weaker cuticle structure, indicated by higher permeability to a DNA dye, but
exhibited no obvious morphological defects. In addition, fluorescent labeling of HPX-2 revealed
its expression in the pharynx, an organ in which BLI-3 also resides. Interestingly, loss of HPX-2
increased intestinal colonization of E. faecalis, suggesting its role in the pharynx may limit
intestinal colonization. Moreover, disruption of a catalytic residue in the peroxidase domain of
HPX-2 resulted in decreased survival on E. faecalis, indicating its peroxidase activity is required
for pathogen resistance. Finally, RNA-seq analysis of an hpx-2 mutant revealed changes in
genes encoding for cuticle structural components under the non-pathogenic conditions. Under
pathogenic conditions, genes involved in infection response were differentially regulated to a
greater degree, likely due to increased microbial burden. In conclusion, the characterization of
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the heme-peroxidase, HPX-2, revealed that it contributes to C. elegans pathogen resistance
through a role in generating cuticle material in the hypodermis and pharynx.

vi

Table of contents
Approval Sheet…………………………………………………………………………………………….i
Title Page…………………………………………………………………………………………………..ii
Dedication…………………………………………………………………………................................iii
Acknowledgments…………………………………………………………………………....................iv
Abstract…………………………………………………………………………………………………....v
Table of Contents………………………………………………………………………………………..vii
List of Figures……………………………………………………………………………………………..x
List of Tables………………………………………………………………………………………….....xiii
CHAPTER 1: INTRODUCTION .................................................................................................... 1
ROS IN INNATE IMMUNITY ........................................................................................................... 2
NADPH OXIDASES (NOXS), DUAL OXIDASES (DUOXS), AND PEROXIDASES ............................... 5
MITOCHONDRIAL ROS .............................................................................................................. 10
C. ELEGANS AS AN INFECTION MODEL ........................................................................................ 12
CHAPTER 2 MATERIALS AND METHODS .............................................................................. 20
CHAPTER 3 HPX-2 CONTRIBUTES TO PATHOGEN RESISTANCE IN C. ELEGANS .......... 31
INTRODUCTION ......................................................................................................................... 32

vii

RESULTS .................................................................................................................................. 34
DISCUSSION ............................................................................................................................. 54
CHAPTER 4: HPX-2 FUNCTIONS IN PHARYNX AND HYPODERMIS AS A PUTATIVE
PEROXIDASE FOR PATHOGEN RESISTANCE ...................................................................... 56
INTRODUCTION ......................................................................................................................... 57
RESULTS .................................................................................................................................. 58
DISCUSSION ............................................................................................................................. 74
CHAPTER 5 TRANSCRIPTOME ANALYSIS REVEALS THAT HPX-2 MUTANT
MISREGULATES GENES FOR CUTICLE SYNTHESIS AND HAS A STRONGER RESPONSE
TO INFECTION. ......................................................................................................................... 77
INTRODUCTION ......................................................................................................................... 78
RESULTS .................................................................................................................................. 79
DISCUSSION ............................................................................................................................. 96
CHAPTER 6 CONCLUSIONS AND PERSPECTIVES .............................................................. 99
SUMMARY .............................................................................................................................. 100
DISCUSSIONS AND FUTURE DIRECTIONS .................................................................................. 102
REFERENCES ......................................................................................................................... 110
VITA .......................................................................................................................................... 125

viii

List of Figures
Figure 3.1 Survival of worms on E. faecalis OG1RF following exposure to vector control
(VC) RNAi, (A) hpx-2 RNAi and (B) hpx-3 RNAi. ............................................................. 36
Figure 3.2 Microinjection and screen for CRISPR mutants. ................................................. 37
Figure 3.3 DNA sequence of HPX-2 and HPX-3 CRISPR mutants. ....................................... 38
Figure 3.4 Schematic representation of HPX-2 mutants. ...................................................... 39
Figure 3.5 Schematic representation of HPX-3 mutants. ...................................................... 40
Figure 3.6 Survival of hpx-2 mutants on E. faecalis. ............................................................. 41
Figure 3.7 Survival of hpx-3 mutants on E. faecalis .............................................................. 42
Figure 3.8 HPX-2 does not contribute to the overall fitness of the worm on E. coli .......... 44
Figure 3.9 HPX-2 does not contribute to the overall fitness of the worm on vancomycin
inactivated E. faecalis. ...................................................................................................... 45
Figure 3.10 hpx-2 mutant adults exhibit the same average size and morphology of N2
worms. ................................................................................................................................ 46
Figure 3.11 hpx-2 mutants have comparable brood sizes compared to N2 worms. .......... 47
Figure 3.12 HPX-2 contributes to C. elegans resistance to some pathogens. ................... 49
Figure 3.13 Genomic hpx-2 complementation rescues the susceptibility to E. faecalis ... 50
Figure 4.2. HPX-2 functionally localizes to the hypodermis of the worm. .......................... 60
ix

Figure 4.3. hpx-2 is expressed in the pharynx. ...................................................................... 61
Figure 4.4. The cuticle defect of hpx-2 mutants. ................................................................... 64
Figure 4.5. Overexpression of HPX-2 results in susceptibility to E. faecalis. ( .................. 65
Figure 4.6. Intestinal colonization of hpx-2 mutants by pathogens. .................................... 67
Figure 4.7. hpx-2 mutants exhibit normal pharyngeal traits. ................................................ 68
Figure 4.8 Amplex red assay of N2 and hpx-2(dg047) mutant. ............................................ 71
Figure 4.9. HPX-2 peroxidase activity is required for pathogen resistance ........................ 72
Figure 5.1 qRT-PCR validation of 10 selected genes differentially expressed in the RNAseq analysis of hpx-2(dg047) to N2 on E. faecalis. ........................................................ 85
Figure 5.2. Scatter plot of genes changed in hpx-2(dg047) animals, as compared to N2
animals, when either exposed to E. coli (x-axis) or E. faecalis (y-axis). ...................... 86
Figure 5.3. Scatter plot of genes changed under pathogenic conditions, as compared to
non-pathogenic conditions, in either N2 strain (x-axis) or hpx-2 mutant (y-axis). ...... 95
Figure 6.1 No interaction between BLI-3 and the two peroxidases (HPX-2 and SKPO-1) is
detected by Yeast-2-hybrid. ............................................................................................ 109

x

List of Tables
Table 1.1 Localization and function of mammalian NOX/DUOX family. ................................ 6
Table 1.2 Localization and function of some of the mammalian peroxidases. ..................... 9
Table 1.3 C. elegans pathogens. ............................................................................................. 14
Table 2.1 Strains used in this study. ....................................................................................... 28
Table 2.2 Oligonucleotides used in this study. ...................................................................... 29
Table 2.3 Primers used in qRT-PCR ........................................................................................ 30
Table 3.1 Median survival and P-values in killing assays ..................................................... 53
Table 4.1 Median survival and P-values in killing assays ..................................................... 73
Table 5.1: GO Term analysis of genes that changed upon loss of HPX-2 (hpx-2(dg047))
compared to N2, when exposed to E. coli OP50. ........................................................... 80
Table 5.2: GO Term analysis of genes that changed upon loss of HPX-2 (hpx-2(dg047))
compared to N2, when exposed to E. faecalis OG1RF. ................................................. 84
Table 5.3: GO Term analysis of genes that changed in N2 strain under pathogenic
conditions (exposed to E. faecalis OG1RF) compared to non-pathogenic conditions
(exposed to E. coli OP50). ................................................................................................ 90
Table 5.3: GO Term analysis of genes that changed in hpx-2 mutant strain under
pathogenic conditions (exposed to E. faecalis OG1RF) compared to non-pathogenic
conditions (exposed to E. coli OP50). ............................................................................. 94
xi

Chapter 1: Introduction
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ROS in innate immunity
Reactive Oxygen Species (ROS) production is one of the first responses from host cells
when infection occurs. After successful pathogen recognition, superoxide (O2-) and/or its
dismutase product hydrogen peroxide (H2O2) are generated for two major purposes: 1) to serve
as signal molecules and activate downstream immune factors and 2) to generate the oxidative
burst and directly eliminate pathogens.
ROS as immune signals
The function of ROS as an indirect signal for activation of the immune response has
been demonstrated in multiple organisms. In plants, ROS were shown to be involved in the
hyper-sensitive response (HR) - a form of programmed cell death (PCD) in multiple species
including Arabidopsis thaliana, Glycine max (soybean), and Nicotiana tobacum (tobacco) (1-4).
Upon activation of the HR, ROS are produced by the plant NADPH oxidase respiratory burst
oxidase homologue (RBOH) and glycolate oxidase (GOX) (1-4). ROBH generates O2- that can
be converted into H2O2 by superoxide dismutase, whereas GOX directly produces H2O2 from
the glyoxylate reaction. Once the level of H2O2 reaches the 6 mM threshold in the infected cells,
HR-mediated PCD is triggered in a calcium-mediated fashion, resulting in the death of the
infected cells and preventing the spread of the pathogen (3-5). In other instances, ROS
associate with salicylic acid (SA), a plant signaling molecule involved in the defense response,
to trigger the systematic acquired resistance (SAR) (6).
In Drosophila melanogaster, ROS play an important role as signal molecules for gut-tofat body innate immune communication (7). Specifically, intestinal infection by enterobacteria
Erwinia carotovora carotovora 15 (Ecc15) in Drosophila larva results in localized ROS
production in the intestine, which then induces nitric oxide (NO) production. The elevated NO
level in the intestine triggers a global immune response in the fat body, a major immune organ
2

in insects, resulting in the production of an anti-microbial peptide (AMP) called diptericin. This
process ensures the systematic control and confinement of the pathogen to the intestine (7, 8).
In zebrafish, ROS, specifically H2O2, serve as signal molecules for recruiting leukocytes
to the wounded sites (9). Using a genetically encoded H2O2 reporter, it was shown that an
increasing concentration gradient of H2O2 from the injured fish tail fin to the nearby areas leads
to the rapid recruitment of leukocytes to the injured site (9). This process requires a dual
oxidase (DUOX) and DUOX inhibition disrupts the gradient, abolishing leukocyte recruitment
(9).
In humans, the signaling function of ROS was first illustrated through the discovery that
micromolar concentrations of H2O2 activate the NF-κB transcription factor in T cells (10). More
recently, it has been demonstrated that H2O2 produced by DUOX2 is involved in NOD2dependent signal transduction resulting in protection against Listeria monocytogenes infection in
epithelial cells (11).
ROS as antimicrobial effectors
Next, I will discuss how ROS serve as a direct antimicrobial reagent during infection with
an emphasis on mammalian systems. While O2- and H2O2 are not considered strong
microbicidal reagents, they can be converted into other oxidants that exhibit stronger
antimicrobial activity. Peroxidases are the enzymes that carry out such reactions. A canonical
example is the oxidative burst in macrophages and neutrophils, generated by formation of the
potent bacterial cytotoxin hypochlorous acid (HOCl). Specifically, when bacteria are engulfed by
neutrophils, H2O2 produced by an NADPH oxidase (NOX2, specifically, see next section) is
subsequently converted into HOCl through a reaction with chloride ion catalyzed by
myeloperoxidase (MPO) (reviewed in (12). HOCl generated in the phagolysome modifies
tyrosine residues in the bacterial protein, forming 3-chlorotyrosine which serves as a marker for
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bacterial killing (13, 14). Mutations in the NADPH oxidase or MPO results in decreased amounts
of 3-chlorotyrosine bound bacterial protein and insufficient microbial clearance (12, 14).
Another example of ROS serving as direct effectors for pathogen elimination is the
generation of the potent antimicrobial anion hypothiocyanite (OSCN-) through the oxidation of
thiocyanate (SCN-) by lactoperoxidase (LPO) using H2O2 produced by dual oxidase (DUOX) as
a substrate (15-18). During Pseudomonas aeruginosa infection of bronchial epithelial cells, the
levels of H2O2 and subsequently OSCN- are increased, contributing to increased pathogen
clearance (19). In addition to P. aeruginosa clearance, OSCN- is also involved in
Staphylococcus aureus and Burkholderia cepacia clearance (19, 20). Disruption of the DUOXLPO-SCN- system would lead to a decrease in pathogen clearance efficiency. For example,
inhibition of LPO activity leads to decreased pathogen clearance in sheep airways (15).
Additionally, cystic fibrosis (CF) patients with mutated CF transmembrane conductance
regulator (CFTR), which causes impaired transport of SCN- to the apical membrane and
decreased production of OSCN-, cannot efficiently clear P. aeruginosa and S. aureus from their
airways (19, 20).
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NADPH Oxidases (NOXs), Dual Oxidases (DUOXs), and Peroxidases
As mentioned before, ROS serve as both signal molecules and microbicidal effectors in
response to infection. NADPH oxidase (NOX) and dual oxidase (DUOX) produce ROS in the
form of superoxide (O2-) and H2O2 whereas peroxidases can utilize the H2O2 to carry out further
reactions such as generating a more potent anti-microbial oxidant.

NOX and DUOX
Five NOX (NOX1-5) and two DUOX (DUOX1 and 2) enzymes have been identified in
mammalian cells (21). NOXs are transmembrane proteins that harbor the NADPH domain and
flavin adenine dinucleotide (FAD)-binding domain, six transmembrane domains, and four
evolutionally conserved histidine residues for heme-binding and catalytic activity (21).
Expressed at different tissue/cellular locations, NOX/DUOX family members produce either
superoxide or hydrogen peroxide that function in a variety of cellular processes including protein
modification, redox signaling, apoptosis, and host defense (Table 1.1) (21, 22) (23). NOX2, or
phagocytic NOX, was the first member discovered in the NOX/DUOX family and was
characterized as generating the oxidative burst in macrophages and neutrophils for host
defense (24). Mutations in NOX2 cause Chronic Granulomatous Diseases (CGD) with
significant increased susceptibility to a variety of pathogen infections (24).
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NOX/DUOX

Location

Function

NOX1

Colon

Host defense

NOX2
(phagocytic
NOX)
NOX3

Phagolysome of macrophage and
neutrophil

Oxidative burst for host defense

Inner ear

Otoconia morphogenesis

NOX4

Kidney, vascular cells, osteoclasts

unclear

NOX5

Lymphoid tissue and testis

Signaling process

DUOX1

Thyroid and respiratory epithelia

Thyroid hormone synthesis and
epithelia host defense

DUOX2

Thyroid and gastrointestinal glandular
epithelia

Thyroid hormone synthesis and
epithelia host defense

Table 1.1 Localization and function of mammalian NOX/DUOX family. This table is a
summary of a mini-review listed in the reference as (25).
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DUOXs are structurally different from NOXs in that they possess an extracellular
peroxidase-like domain at their N-terminus. Functionally, instead of producing O2-, DUOXs
produce H2O2 through oxidation reactions. In addition to host defense function in mammals,
DUOXs also play an important role in the stabilization of the extracellular matrix by crosslinking
tyrosine in multiple organisms including Drosophila and Anopheles gambiae (26, 27).
In C. elegans, the only functional NOX/DUOX is BLI-3 (also known as Ce-DUOX1) was
characterized for its role in maintaining extracellular matrix integrity, protecting worms from
infection, and regulating the oxidative response. Similar to human DUOX1 and DUOX2, BLI-3
possesses a highly conserved NADPH and FAD binding domain at its C-terminus and an
extracellular peroxidase domain at the N-terminus (28). Functionally, both its NADPH oxidase
and peroxidase activity are important for cuticle crosslinking (28, 29). Cuticle is the collagenous
extra cellular matrix that serves as the exoskeleton of the worm, providing structure and
protection from the environment (30). RNAi knockdown of BLI-3 or mutations in either domain
result in severe cuticle blistering due to the insufficient di- and tri- tyrosine crosslinking of
collagen proteins (29). A heme peroxidase, MLT-7, is also involved in the tyrosine cross-linking
process, presumably by utilizing the H2O2 generated by the BLI-3 NOX domain as a cosubstrate (29). In addition to cuticle crosslinking, BLI-3 is also involved in pathogen resistance
and the response to oxidative stress through the p38 MAPK and insulin signaling pathways (see
the last section in this chapter for more detail).
Given the function of BLI-3 in cuticle cross-linking, innate immunity, and oxidative stress
response, multiple internal and external signals can activate its expression and activity. The
expression of BLI-3 peaks during the molting cycle, corresponding to cuticle biosynthesis.
Additionally, environmental stress such as pathogen infection and oxidative stress stimulate its
activity, resulting in an increased amount of ROS.
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Peroxidases

Heme peroxidases catalyze a variety of oxidative reactions by utilizing H2O2 as an
electron acceptor and heme as redox cofactor. The four families of peroxidases are 1) the
catalase superfamily, aka bacterial, fungi, and plant peroxidase superfamily 2) the
cyclooxygenase superfamily, aka animal peroxidase superfamily (although members of the this
group include non-animal species) 3) the chlorite dismutase superfamily and (4) the
peroxygenase superfamily (32). All the mammalian peroxidases belong to the cyclooxygenase
super family (32). Some well-studied examples include eosinophil peroxidase (EPO), thyroid
peroxidase (TPO), and previously mentioned MPO and LPO. Their differential expression,
location and function are listed in Table 1.2.
Peroxidases in the cyclooxygenase family shares two conserved sequence signatures: X-G-Q-X-X-D-H-D-X- and -X-R-X-X-E-X- (32). The first sequence is characterized by the distal
catalytic histidine and two aspartates that are involved in heme-binding. The second conserved
sequence includes a highly conserved catalytic arginine residue followed by a glutamate that is
involved in forming an ester bond with heme (32). In human MPO, the crucial catalytic residues
are Gln257, His261, and Arg405, with the function of forming the binding pockets for H2O2 (33).
The latter two residues (His 261 and Arg 405) are also shown to be conserved in plant and
yeast peroxidases (34, 35). In C. elegans, the distal histidine and arginine are present in all the
peroxidases identified including MLT-7, SKPO-1, and HPX-2. The only exception is the
peroxidase domain of the DUOX BLI-3, where the distal histidine has been replaced by a
tyrosine residue (Tyr106) (Figure 4.9), which is believed to cause its slower turnover rate
compared to other mammalian peroxidases (36). Functionally, mammalian heme peroxidases
are capable of oxidizing small aromatic substrates as well as iodide (I-), thiocyanate (SCN-), and
bromide (Br-), giving rise to their various functions in protein modification and generation of
antimicrobial substances (33).
8

Peroxidase

Location

Function

MPO

Neutrophils and macrophages

Oxidative burst for host defense

LPO

Leukocytes in milk, tears, and saliva

Bactericidal compound production

EPO

Eosinophils

Bactericidal compound production

TPO

Thyroid gland

Thyroid hormone production

Table 1.2 Localization and function of some of the mammalian peroxidases. This table is a
summary of a review listed in the reference as (33).
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Mitochondrial ROS
In addition to NOX/DUOX enzymes, mitochondria are also a major source of ROS
(mtROS). As a crucial cellular organelle, the most prominent function of mitochondrion is to
generate ATP by a serious of oxidation reactions in the electron transport chain. mtROS are
produced as a major by-product during the process. Although traditionally mtROS are viewed
as destructive molecules that cause a variety types of cell damage, they are also involved in
various metabolic and innate immunity signaling pathways that are beneficial and homeostatic
(37, 38). Similar to the NADPH derived ROS, mtROS can function as a direct source of
antimicrobial oxidants or as a signal to regulate innate immune responses in mammals (39). In
C. elegans, although mtROS have been shown to function in promoting hypodermal wound
healing and longevity under stress conditions, their roles in innate immunity have not been
characterized (40, 41).
Complex I, the largest complex of the respiratory chain, is the major source of mtROS
(39). During a bacterial infection, mtROS production is stimulated and mitochondria are directed
towards newly formed phagosomes to join forces with NADPH-derived ROS for the bacteria
eliminating oxidative burst (39). This process is regulated by multiple pathways starting from
Pathogen Associated Molecular Pattern (PAMP) recognition by host cells. Upon successful
recognition of pathogenic microbes, four distinct and partially overlapping signaling pathways
are activated, resulting in: 1) NADPH oxidase activation and increased ROS production in the
phagosome, 2) Proinflammatory cytokine production, 3) Release of the ubiquitin ligase TRAF6
from Rac-GDP which promotes TRAF6-ECSIT compound formation, and 4) Serine-threonine
kinases Mst1/2 activation. These four pathways all have positive roles in reducing the oxidative
phosphorylation in Complex I and increasing mtROS formation (42-44). Additionally, the
TRAF6-ECSIT and Mst1/Mst2 pathways contribute to the movement of ROS-enriched
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mitochondria towards the phagosome through the activation of F-actin assembly by the
production of Rac-GTP (45, 46).
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C. elegans as an infection model
C. elegans pathogens
C. elegans is a classic model organism in which fundamental biological processes, such
as development and aging, have been studied since the 1970s (47-49). Only in the past two
decades has it become a popular model for infectious diseases. Its simplified immune system
and well-characterized biology make it ideal to study host-microbe interactions. As of today, a
large number of pathogens, including fungi, bacteria, and even viruses of clinical relevance,
have been demonstrated to effectively infect C. elegans (50). Generally speaking, there are two
major modes by which microbes harm C. elegans: (1) secretion of toxins and (2) colonization
and physical disruption of the worm body. These two mechanisms of causing disease in the
worm apply to many pathogens, sometimes in a non-mutually exclusive way. In terms of the site
of infection, the intestinal lumen and the hypodermis are the two major locations where infection
starts. In this section, I will discuss some of the fungal and bacterial pathogens for which C.
elegans is utilized as an infection model.
One of the well characterized fungal pathogens is Candida albicans, an opportunistic
pathogen that can also be found as a commensal of the human microbiome. C. albicans can
colonize the intestine of the worms, causing distal intestinal distention (51). Unlike live C.
albicans, heat-killed C. albicans were avirulent, suggesting the pathogenesis is not mediated by
toxins (51) . In contrast to C. albicans, another fungal pathogen, Cryptococcus neoformans, kills
C. elegans independently of whether the microbe is alive, indicating that the mode of killing is
through the production of toxin (52, 53) . In addition to intestinal colonization, some fungal
species infect the worms through the cuticle. One example is Drechmeria conisopora, a natural
pathogen of C. elegans. It utilizes its conidia to adhere to the head and vulva of the worm, then
invades the worm body by penetrating the cuticle around the head and through the natural
orifice around the vulva (54).
12

Pseudomonas aeruginosa is probably the most studied bacterial pathogen in C. elegans
and indeed was the first pathogen ever reported to infect! Depending on the culture media
conditions, P. aeruginosa utilizes either toxin-mediated killing or colonization of the intestine to
kill C. elegans (55, 56). “Fast-killing” occurs when P. aeruginosa is grown under nutrient rich
and high osmolarity conditions in which the bacteria secrete various toxins to mediate killing of
the worms in a matter of hours. On the other hand, “slow-killing” is when bacteria are grown on
minimal media, colonize the intestine, and kill the worms over the course of a few days. Slowkilling requires live bacteria whereas fast-killing does not. P. aeruginosa is not the only bacteria
that secretes toxins/effectors that kill C. elegans. Many other bacteria have similar mechanisms
of killing, although the effectors they produce varies. Some of the other toxin producing bacteria
include E. coli EHEC (Shiga toxin) (57), Baccillus thuringiensis (pore-forming crystal protein)
(58), Staphylococcus aureus (α-hemolysin) (59), and many Streptococcus species including S.
pyogenes (hydrogen peroxide) (60).
Enterococcus faecalis is another important human pathogen that can be found in the gut
flora of healthy individuals. This Gram-positive bacterium can cause a variety of diseases in
immune compromised patients and is a leading cause of nosocomial infection. E. faecalis kills
C. elegans by intestinal colonization and propagation with an LT50 of about 4 days (61).
Transmission electron microscopy (TEM) revealed actively dividing bacteria in the intestine (72).
E. faecalis also prevents C. elegans from propagating, although adults will lay eggs onto the
bacteria lawn; none develop into adults. Consistent with other animal models, mutations in the
major quorum sensing regulatory system, fsr, or in two extracellular protease encoding genes,
gelE and/or sprE, attenuate killing (62, 63). In addition, production of cytolysin, a toxin that can
lyse host cells, significantly increased the rate of killing (62, 64).
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Kingdoms Pathogens
P. aeruginosa

Infection and
Pathogenic Mode
Feeding; slow killing by
colonization; fast killing
by toxin

Bacteria
S. enterica

Feeding; killing by
colonization; LPS as
virulence factor

S. aureus

Feeding, α-hemolysin as
virulence factor

C. diphtheriae

Feeding, diphtheriae toxin
and pili as virulence
factor
Feeding, killing by
colonization
Feeding, killing by
colonization and toxins
Feeding; colonization;
hydrogen peroxide as
virulence factor
Feeding; colonization

E. faecalis
E. coli (EHEC)
S. pyogenes
Fungi

C. albicans

C. neoformans

Drechmeria
coinospora

Feeding; colonization;
laccase; polysaccharide
capsule and/or
melanization as virulence
factors
Attachment and
penetration through
cuticle

Host Pathway
and Response
PMK-1, ZIP-2,
FSHR-1
dependent
pathways
PMK-1dependant
programed cell
death pathway
SEK-1 and
NSY-1
dependent p38
MAP kinase
pathway and
TFEB mediated
transcriptional
response
Not analyzed

References
(55) (65, 66)
(67)
(68)

(59, 69)

(70)

p38 MAP kinase (62, 71)
pathway
Not analyzed

(60)

PMK-1/p-38
MAPK
pathways
CED-1,
C03F11.3 and
ABL-1
dependent
pathways

(51)
(52, 53)

(54)

Table 1.3 C. elegans pathogens. This table was adapted and modified from a previous
publication and the article is listed for reference (50).
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C. elegans innate immunity
Generally speaking, the Innate immune process consists of three steps: 1) Pathogen
recognition by host receptors; 2) Signal transduction through phosphorylation and transcriptional
regulation and 3) Production of effectors that achieve immunity. In this section, I will briefly
discuss current knowledge of the components of the each of these steps.

Pathogen recognition
During microbial infection on start, host sense the infection through two major
mechanisms: through the recognition of pathogen associated molecular patterns (PAMPs) (73),
or though damage associated molecular patterns (DAMPs) (74, 75).
In C. elegans, the PAMP-associated pathogen recognition pathway has not been well
defined, largely due to the lack of conserved pattern recognition receptor(s) (PRR) being
identified in the C. elegans genome. The only Toll-like Receptor homologue, TOL-1, in C.
elegans is not involved in direct pathogen recognition (76). In addition, C. elegans lacks the
peptidoglycan receptors or the NOD-like receptors (77). However, studies have shown that both
live and heat-killed pathogens, i.e. C. albicans and E. faecium, induced similar immune
responses in C. elegans, suggesting there are mechanisms to recognize pathogen-associated
patterns (78, 79). In the search for immune receptors, one candidate identified was the G
protein-coupled receptor FSHR-1 (66). FSHR-1 is a surface protein containing evolutionary
conserved extracellular leucine-rich repeat (LRR) domain that is present in many other
pathogen receptors in animals and plants (66). However, it is unclear whether FSHR-1 directly
recognizes infection and its pathogen ligand is yet to be identified (66, 80).
In addition to direct PAMP-recognizing mechanisms, C. elegans can also recognize
pathogen induced damage and activate downstream immune responses. Examples include
epidermis and cuticle disruption by physical force, causing activation of the PMK-1 pathway,
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similar to epidermal fungal infection (81, 82), and pore-forming toxins causing activation of the
PMK-1 pathway in the intestine (83). More recently, a G protein-coupled receptor (GPCR),
DCAR-1, was identified as a potential sensor for fungal infection and cuticle defects (84). The
endogenous ligand of DCAR-1 is thought to be the 4-hydroxyphenyllactic acid (HPLA), a
tyrosine derivative that has increased presence during infection and cuticle alteration (84).

Signal transduction
In contrast with the uncertainty and speculation in the pathogen recognition research
areas, signal transduction pathways in C. elegans are much more well-defined. Two major
signaling pathways, the p38 MAPK pathway and the DAF-2/DAF-16 insulin signaling pathway,
have been characterized for their functions during infection and many other stress-related
responses.
The p38 MAPK pathway is an evolutionally conserved signaling pathway across diverse
organisms, regulating not only innate immunity, but also stress responses. It has been well
studied in yeast and mammals for its involvement in osmotic stress response (85), abiotic stress
response, and innate immune response (86) (87). In C. elegans, the p38 MAPK pathway is
activated in the intestine, hypodermis, and neurons during various infections. The core
components include the MAPK, NSY-1, the MAPKK, SEK-1, and the MAPKKK, PMK-1. Loss of
PMK-1 result in significant increases in susceptibility of C. elegans to multiple pathogens,
including Gram-negative bacteria such as P. aeruginosa (71, 88) and S. enterica (68), Grampositive bacteria such as E. faecalis (89) and S. aureus (59), and the fungal pathogen C.
albicans (51). In addition, loss of the upstream components, NSY-1 and SEK-1, also result in
enhanced killing during P. aeruginosa infection (71, 90).
The DAF-2/DAF-16 insulin signaling pathway regulates aging, metabolism, and
development in C. elegans (91). It also plays an important role in innate immunity (61). DAF-2,
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the insulin-like receptor, inhibits the activity of the downstream transcription factor DAF-16
through a cascade of phosphorylation of AGE-1, PDK-1, and AKT-1 (92). Constitutive activation
of DAF-16 results from loss of function mutations in daf-2 or age-1 resulting in significantly
increased resistance to multiple pathogens including P. aeruginosa, S. aureus, and E. faecalis
(61).
Effector production
Antimicrobial effector secretion is a frequent result of innate immune signaling and plays
an important role in pathogen clearance. In C. elegans, there are multiple types of effectors that
have been demonstrated to have protective roles against pathogens. The saposin-like
amoebapores (SPPs) and Anti-Microbial Peptides (AMPs) were the first ones to be discovered.
C. elegans encodes a large number of SPPs that function in multiple tissues including the
pharynx and the intestine to exert their antimicrobial function. Recombinant SSPs expressed in
E. coli exhibited microbicidal activity (93). AMPs are antimicrobial peptides encoded by abf-1
and abf-2 genes (94). They are expressed in the pharynx and the intestine and experiments
with recombinant protein showed strong antimicrobial activity against bacteria and fungi (94).
Through expression profiling and sequence homology analysis, lysozymes, another family of
immune effectors was identified (95). Overexpression of the lys-1 gene increased C. elegans
resistance to Serratia marcescens (95). Another important effector family is C-type lectins
(CLEC), many of which are induced during infection and participate in immune defense
(reviewed in (96) . For example, purified CLEC-39 and CLEC-49 bound to S. marcesecens, and
mutations in the clec-39 and clec-49 genes resulted in increased susceptibly to this pathogen
(95, 97).
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Roles of DUOX and peroxidases in C. elegans innate immunity
As discussed in the beginning of this chapter, ROS production is one of the first innate
immune responses upon successful pathogen recognition. In C. elegans, the NADPH dual
oxidase ce-DUOX1(BLI-3) is the major source of ROS. BLI-3 was first discovered for its critical
role in cuticle cross-linking and was found to be present in the hypodermis (28). Later, it was
demonstrated that BLI-3 is responsible for the increased level of H2O2 observed when worms
are infected by E. faecalis, and RNAi knockdown of BLI-3 result in a significant increase in
pathogen sensitivity (98, 99). More recently, mCherry::BLI-3 transgene revealed that in addition
to its hypodermis localization, BLI-3 was also produced in the pharynx and intestine (100). It is
also shown that BLI-3 generated ROS activates the p38 MAPK pathway, resulting in the nuclear
localization of stress response regulator SKN-1, a Nrf2 orthologue in mammalian system, and
activation of detoxification genes (101). In the same study, it was established that SKN-1 is
required for pathogen resistance. A model was proposed for BLI-3-mediated SKN-1 activation
(103). Together, these findings implicated a role for ROS production in immune signaling. It also
highlighted the significant cross-talk and overlap between stress response and innate immune
pathways.
Interestingly, while the NADPH oxidase domain of BLI-3 is required for both pathogen
resistance and cuticle cross-linking functions, the peroxidase domain is dispensable for
pathogen resistance (99). This led to the speculation that a partner peroxidase might be
involved. Indeed, a peroxidase, SKPO-1, which functions in pathogen resistance, was
discovered (102). Loss of SKPO-1 not only resulted in incomplete penetration of dumpy
phenotype, but also significantly increased C. elegans susceptibility to E. faecalis, suggesting
that SKPO-1 plays a role in cuticle cross-linking and pathogen resistance (102). A skpo-1
mutant produced an even higher level of H2O2 compared to N2 when exposed to pathogen,
indicating a possible function in H2O2 consumption - perhaps modulating the levels of this
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oxidant during infection (102). Furthermore, SKPO-1 localizes to the hypodermis of the worm, a
tissue in which BLI-3 also resides (102). However, whether or not there is a physical interaction
between BLI-3 and SKPO-1 is unknown.
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Chapter 2 Materials and Methods
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Strain Maintenance
C. elegans strains were grown and maintained as previously described (104). The hpx-2
nonsense mutation strain VC20223 hpx-2(gk252521) was obtained from the Caenorhabditis
Genetic Center and was backcrossed with N2 Bristol six times. C. elegans strains, bacterial
strains, and fungal strains used in this study are listed in Supplemental Material, Table S5. For
experiments requiring synchronized worms, L1 stage worms on starved plates were washed off,
filtered through a 10µm filter (pluriSelect, pluriStrainer 10µm) spun down, transferred to seeded
plates, and grown to the desired stage.

Strain Construction
To generate the hpx-2(dg047) CRISPR knock-out strain, single guide (sg) sequences
were designed by WU CRISPR (http://crispr.wustl.edu) using the un-spliced sequence of the
hpx-2 gene. Four 18 bp sg sequences with WU score higher than 65 were selected and
separately cloned into pJW1219 (105). A mixture of four plasmid constructs was injected into N2
worms at a concentration of 10 ng/µl each, and with 10 ng/µl of pJW1219-dpy-10 as a coCRISPR marker. Worms that displayed a roller or dumpy phenotype were then isolated for
genotyping to test for insertions and/or deletions (INDEL) in the hpx-2 gene. Verified hpx-2
mutants were backcrossed with N2 to eliminate the dpy-10 mutation.
The HPX-2 catalytic residue mutant (HPX-2-R372A), PHX782 hpx-2(syb782), was
generated by Suny Biotech (http://www.sunybiotech.com) using CRISPR-Cas9. The mutant
strain PHX782 hpx-2(syb782) was verified by PCR sequencing and the primers are listed in
Table S6.
To generate the hpx-2 complemented strains, a 12 kb DNA fragment containing the hpx2 gene and 5 kb of upstream and 4 kb of downstream sequences was amplified from the
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genomic DNA of N2 worms. The PCR product was then purified and injected into hpx-2(dg047)
and hpx-2(gk252521) at 20 ng/µl concentration with 50 ng/µl of EcoRV-digested genomic DNA
from N2 worms. pCFJ90 (pMyo2::mCherry) was used as a fluorescent co-injection marker at a
final concentration of 2 ng/µl.
To visualize hpx-2 expression, the GF203 strain was generated by injecting the
pPD95.75 (50 ng/µl) plasmid containing the 4 kb upstream of hpx-2 and the first two exons
fused to gfp, with 20 ng/µl pRF4 (rol-6(su1006)) as a roller co-injection marker. The obtained
strains with extrachromosomal arrays were then exposed to trimethylpsoralen (TMP) with UV
irradiation and back crossed six times to generate stable integrated transgenic lines using a
previously described protocol (106). All the oligonucleotide primers used in this study are listed
in Table S6.

Killing and Longevity Assays
Killing assays and longevity assays were conducted as previously described, with some
slight modifications (61, 62, 107). All assays were done with 30 worms at the L4 stage worms
on three replica plates (or 6-plate wells for the C. albicans assay) for a total of 90 animals and
scored for survival over time. For plate preparation, E. faecalis OG1RF was grown in BHI for 5
hours and seeded onto BHI agar plates with 50 µg/ml of gentamycin and grown overnight at
37°C. P. aeruginosa PA14 was grown in LB broth overnight and seeded onto SK plates,
incubated at 37°C for 24 hours, and then 25°C for another 24 hours. S. enterica SL1344 was
grown in LB overnight and seeded onto SK plates and incubated at 37°C overnight. S. aureus
NCTC8325, grown in TSB with 10 µg/ml nalidixic acid (Nal) overnight, was seeded to TSA+Nal
plates and incubated at 37°C for 6 hours. C. diphtheriae NCTC13129 grown in BHI overnight
was seeded onto BHI plates containing 25 µg/ml Nal and 50 µg/ml 5-fluoro-2-deoxyuridine
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(FuDR) and incubated at 37°C for 24 hours. C. albicans strain SC5314 was grown overnight in
BHI media and spotted onto solid BHI plates. L4 stage worms were exposed to C. albicans for 4
hours and were collected, washed, and transferred to six-well plates containing 20% BHI and
80% M9W, and scored for survival daily (108).

RNA interference
To knock down hpx-2 gene expression, L1 to L4 stage larvae were exposed to E. coli
HT115 containing the expression plasmid for double-stranded hpx-2 previously constructed
(109). L4 stage worms were then transferred to E. faecalis killing plates for the pathogen
susceptibility assay.

Fluorescence microscopy
To visualize HPX-2::GFP expression, worms with the roller phenotype indicative of the
co-injection marker were picked and anesthetized with 25 mM tetramisole and mounted on 2%
agarose pads. The worms were then visualized and imaged using Olympus Fluoview FV3000.
To visualize intestinal colonization by E. faecalis and P. aeruginosa, C. elegans were
exposed to these pathogens for 48 hours (E. faecalis) and 24 hours (P. aeruginosa) respectively
on agar plates. They were then washed off the plates and washed four times with 1 ml of M9W.
Following anesthesia with 25 mM tetramisole hydrochloride, the worms were mounted on 2%
agarose pads for imaging.
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Colony forming unit assay of intestinal colonization
To measure intestinal CFUs, animals were exposed to bacteria as described above and
then washed off plates with M9W. They were then washed three times in 1 ml of M9W, then
twice more with 1 ml of M9W containing 25 mM tetramisole hydrochloride. The worms were
then treated with 500 µl M9W containing 25 mM tetramisole hydrochloride, 1 mg/ml of ampicillin,
and 1 mg/ml kanamycin for 1 hour to kill all surface bacteria. The treated worms were washed
twice more with 1 ml of M9W containing 25 mM tetramisole hydrochloride, transferred to an
Eppendorf tube containing 100 µl of M9 (one worm per tube), and disrupted using a motorized
pestle (Kontes cordless pestle (cat# K749540-0000) and pestles (cat# K749521-1590) for 1 min.
The solution was then serially diluted in M9 and spotted on agar plates for CFU counting.

Hoechst staining
Hoechst staining of the worms was performed as previously described (110).
Specifically, worms were washed off plates with M9W buffer, and then incubated in M9W
containing 1 mg/ml Hoechst 33258 dye (Sigma) at room temperature for 20 minutes with gentle
shaking, followed by three more washes with M9W before imaging. Hoechst-positive worms
were scored based on staining of the epithelial cell nuclei, which is indicative of cuticle
penetration.

RNA isolation and qRT-PCR analysis
L4 animals were exposed for 16 hours to the condition of interest and total RNA was
extracted using Trizol (Invitrogen) according to the manufacturer’s instructions. RNA samples
were treated with Turbo DNA free kit (Applied Biosystems) to eliminate DNA contamination.
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qRT-PCR was performed as previously described (101). The actin gene was used as an internal
control. Primers used in qRT-PCR are listed in Table S7.

RNA sequencing
L4 stage worms were exposed to E. faecalis or E. coli for 16 hours and total RNA was
extracted for 5 biological replicates. Illumina Hiseq 4000 sequencer with 75 nt pair-ended read
format was used to conduct the sequencing. The sequencing reads (ranging from 20 million to
37 million per biological replicate) were quality and adaptor trimmed and mapped to the
reference genome (version WBcel235 downloaded from http://ensemblgenomes.org) using
Tophat (111). The expression level (RPKM) of annotated genes was measured using Cufflink
(112), and differential expression analysis was conducted using Cuffcompare and Cuffdiff (112)
using the gene annotation (Caenorhabditis_elegans.WBcel235.37.gff3 downloaded from
http://ensemblgenomes.org). Gene Ontology analysis was carried out by using DAVID (the
Database for Annotation, Visualization, and Integrated Discovery) 6.8 (113). Gene enrichment
with a Benjamini adjusted P < 0.05 is listed. Genes that were differentially regulated under
different conditions are listed in Table S1-4.

Amplex Red Assay
To measure H2O2 concentration of the worms, the Amplex red assay was performed as
previously described (109) using the Amplex Red hydrogen peroxide/peroxidase kit (Invitrogen
Molecular Probes, Eugene, OR) with the following modifications: L4 worms were exposed to a
bacterial strain for 16 hours and transferred to 96 well plates with 30 worms in each well. A total
of 80 mM diphenyleneiodinium chloride (DPI) (TCI, Tokyo) was added to some wells and
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allowed to incubate for 15 minutes prior to addition of Amplex Reagents. After 1 hour of
incubation, fluorescence was measured at 540/590 nm excitation and emission, respectively.

Pharyngeal pumping Rate
To measure the pharyngeal pumping rate of the worms, contractions of the posterior
pharyngeal bulb were observed and counted over a 10 second interval for 15 adult animals
under a 20X magnification stereo microscope.

Brood size
To measure the brood size of the worms, 9 L4 stage worms were singled on NGM
plates, allowed to lay eggs and transferred to a new plate each day until no more eggs were
produced. The offspring on the plates were counted to calculate brood size.

Statistical Analysis
Survival, longevity assays, qRT-PCR, intestinal CFU, and Hoechst staining data were
analyzed using GraphPad Prism version 5.0 (GraphPad Software, San Diego). Kaplan-Meier
log rank analysis was used to compare longevity and survival curves. An unpaired Student’s ttest was used to determine the statistical significance of the intestinal CFU and Hoechst staining
data. In all the experiments, P-values < 0.05 were considered to be significant and are noted in
the figures with one asterisk indicating P < 0.05, two indicating P < 0.01, three indicating P <
0.001 and four indicating P < 0.0001.
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Strains
Enterococcus faecalis
OG1RF
OG1RF-GFP
Pseudomonas aeruginosa
PA14
PA14-dsRed
Escherichia coli
OP50
HT115(DE3)
EHEC O157:H7
Candida albicans
SC5314
Staphylococcus aureus
NCTC 8325
Salmonella enterica
SL1344
Corynebacterium
diphtheriae
NCTC 13129
Caenorhabditis elegans
N2
Hypodermal RNAi strain

Intestinal RNAi strain
GF200

GF201
GF202
GF203

GF204

Description

References

Wild-type strain, FaR, RfR

(114)
(115)

Wild-type strain
Expresses dsRed

(116)
(117)

Wild-type strain, StrR
Used to express dsRNA for
RNAi in C. elegans, AmpR,
TetR
Outbreak strain

(49)
(71)

Wild-type prototrophic strain

(120)

Prototypical strain

(121)

(118, 119)

(122)
(123)
Wild-type
Tissue-specific RNAi strain,
rde-1(ne129); Is[wrt2prom::RDE-1::unc-54 3’
utr; myo2p::RFP3]
Tissue-specific RNAi strain,
sid-1(qt9); Is[vha-6::sid-1]
hpx-2 nonsense mutation
strain, hpx-2 (gk252521) V
backcrossed 6 time from
VC20223
hpx-2 CRISPR/Cas9
knockout strain, hpx2(dg047) V
hpx-2::gfp expression
strain, dgIs049 [hpx-2p::gfp;
rol-6(su1006)]
hpx-2 complementation
strain, hpx-2 (dg047) V;
dgEx050 [hpx-2p::hpx-2;
myo-2p::mCherry]
hpx-2 complementation
strain, hpx-2 (gk252521) V;
dgEx050 [hpx-2p::hpx-2;
myo-2p::mCherry]
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(49)
(124) (124)

(124) (124)
This study

This study
This study
This study

This study

GF205

GF206

PHX782

hpx-2 overexpression
strain, hpx-2 (dg047) V;
dgEx050 [hpx-2p::hpx-2;
myo-2p::mCherry]
hpx-2 overexpression
strain, hpx-2 (gk252521) V;
dgEx050 [hpx-2p::hpx-2;
myo-2p::mCherry]
hpx-2(syb782)

Table 2.1 Strains used in this study.
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This study

This study

This study

Ss#
40
41
42
43
44
45
46
47
205
206
212
213
257
258

Oligo name
P1-sg1pJW1219-F
P1-sg1pJW1219-R
P1-sg2pJW1219-F
P1-sg2pJW1219-R
P1-sg3pJW1219-F
P1-sg3pJW1219-R
P1-sg4pJW1219-F
P1-sg4pJW1219-R
pHPX2-4kb9567-F
pHPX2-4kb9567-R
HPX2-12KBpBluescript-F
HPX2-12KBpBluescript-R
YL01-seq-s
YL01-seq-a1

Oligo sequence
cct cct att gcg aga tgt ctt g CCA ATG AAG TCA
TTG AAA GA gtt taa gag cta tgc tgg aaa c
gtt tcc agc ata gct ctt aaa c TCT TTC AAT GAC
TTC ATT GG caa gac atc tcg caa tag gag g
cct cct att gcg aga tgt ctt g CGG TTA TTG CAG
TTA ATT GG gtt taa gag cta tgc tgg aaa c
gtt tcc agc ata gct ctt aaa c CC AAT TAA CTG
CAA TAA CCG c aag aca tct cgc aat agg agg
cct cct att gcg aga tgt ctt g CTT CGA TTC GAT
CAA TCA CA gtt taa gag cta tgc tgg aaa c
gtt tcc agc ata gct ctt aaa c TG TGA TTG ATC
GAA TCG AAG c aag aca tct cgc aat agg agg
cct cct att gcg aga tgt ctt g ATG CAG CTC CCA
GAA TTC GG gtt taa gag cta tgc tgg aaa c
gtt tcc agc ata gct ctt aaa c CC GAA TTC TGG
GAG CTG CAT c aag aca tct cgc aat agg agg
GCCTGCAGGTCGACTtacttcttttgtaaattctcctgtatg
aactttttgtg
CCGGGGATCCTCTAGcggtttcaaattcatatttcaaaa
tgaattctaaataatcgg
cactagttctagagcggaagtcattgatcaacccgtgag
accgcggtggcggcccttgtgtgctcttgtaaaatcgcaagc
AACTACCGTCTGCTAGGCTA
TAGATGGATCTACACTGGTAC

Table 2.2 Oligonucleotides used in this study.
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Purpose
Clone hpx-2 single
guide sequence
#1 to pJW1219
Clone hpx-2 single
guide sequence
#2 to pJW1219
Clone hpx-2 single
guide sequence
#3 to pJW1219
Clone hpx-2 single
guide sequence
#4 to pJW1219
Clone 4kb
promoter region of
hpx-2(plus first 5
aa) into pPD95.67
Gibson assembly
of 10KB HPX-2
fragment into
pBluescript
PCR and
sequencing
primers for HPX-2R372A (syb482)

act-1 F
act-1 R
lys-1 F
lys-1 R
lys-2 F
lys-2 R
lys-3 F
lys-3 R
lys-7 F
lys-7 R
spp-20 F
spp-20 R
f53a9.8 F
f53a9.8 R
pmk-2 F
pmk-2 R
col-20 F
col-20 R
col-88 F
col-88 R
hsp12.3 F
hsp12.3 R

ACC ATG TAC CCA GGA ATT GC
TGG AAG GTG GAG AGG GAA G
CCACAGGACAACTTCGAAGTGACT
TGTCTTGAGGCAGTTCATTTGAGAAACT
CGCTTCAATGGGAAATGCTGTCG
CCAACACAATTTGAATCAAAAGCTCCATTT
CTCTATTACATTGTGCTACTCTTTCC
TCATCATATGGAATTGCTGGAGC
TGCATACAACCCAGCAGG
ATGATCTCATCCAACTGTTGGT
CATATTTGCCAGCTTGCTCC
CAACAAATTGAGAGACGAGTACAC
GTCGCACCAAGAACACGGAC
GCCTGATGGTTGCCCCC
GGCGATTCAGCCAGCATTCCCG
CTCCATACGCTCCTTCTCCTAGAGGC
CTATCATTGCCGTGCCAATG
GATCAGAAACAGCGTTAGATCG
TGATGCCTGGAGATCCATG
GGTCCTGGTGGTCCG
CTGGACTACGAAGACCATTTC
AATACTGCGGGTGATAGATCC

Table 2.3 Primers used in qRT-PCR
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Introduction
When exposed to pathogen, production of Reactive Oxygen Species (ROS) is one of the
first innate immune responses initiated by the host. ROS can exert immune-protective effects by
acting directly as an antimicrobial, serving as a signal to activate downstream responses, and/or
contributing to the generation of physical barriers. There are two major groups of enzymes
involved in this process – the ROS producing NADPH oxidases/Dual-oxidases (NOX/DUOX)
and the ROS utilizing, heme-containing peroxidase (reviewed by 22, 125)). In many cases,
these enzymes are functionally, and sometimes physically linked to contribute to innate
immunity against pathogen. The most canonical case studied in mammalian systems is that of
myeloperoxidase (MPO), which resides in the phagolysosome of macrophages and utilizes the
superoxide produced by NOX2 to generate the powerful oxidant HOCl during the oxidative burst
that occurs as a result of microbial engulfment (reviewed by (126)). Additionally, it has been
shown that lactoperoxidase (LPO) coupled with DUOX2, is responsible for the generation of the
antibiotic oxidant hypothiocyanite (OSCN-) from H2O2 and thiocyanate (SCN-) on mucosal
surfaces (16, 18, 127). These responses are not limited to animals; plants also employ
peroxidases and NADPH oxidases as part of their antimicrobial arsenal (reviewed in (128)).
In C. elegans, the one functional NOX/DUOX encoded by the genome is BLI-3, a dual
oxidase that produces H2O2 when animals are exposed to pathogen (28, 98, 99, 129). Like all
dual oxidases, BLI-3 consists of an NADPH oxidase domain and a heme peroxidase domain
(28). The production of H2O2 from the NADPH oxidase domain of BLI-3 is required for pathogen
resistance and point mutants that affect this domain significantly increase pathogen
susceptibility (99, 100). In addition to its role during infection, BLI-3 is crucial for cuticle
development. The peroxidase domain uses the H2O2 produced by the NADPH oxidase domain
to cross-link collagen proteins (28). Another independent heme-binding peroxidase, MLT-7,
additionally contributes to this process (29). Mutations in the peroxidase domains of BLI-3 and
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MLT-7 that impair activity result in a blistered phenotype. However, these mutations do not
affect pathogen susceptibility (102).
Given that NOX/DUOX enzymes and heme-containing peroxidases often functionally
partner, we hypothesized that there might be DUOX-Peroxidase systems in C. elegans that
contribute to pathogen resistance. To test this hypothesis, a previous graduate student in our
lab, Dr. George Tiller, conducted a RNAi screen where he knocked down each of all the putative
peroxidases encoded in C. elegans genome and tested their susceptibility to E. faecalis (102).
He found three putative peroxidases that when knocked down significantly increase pathogen
susceptibility. One, which he named SKPO-1, was characterized in detail in his Ph.D.
dissertation (102). He showed that a skpo-1 mutant was more susceptible to E. faecalis
compared to the N2 reference strain. In addition to pathogen sensitivity, the skpo-1 mutant also
had an incomplete penetrance of dumpy phenotype, suggesting a potential role in the process
of cuticle bio-generation. Interestingly, SKPO-1 localized to the hypodermis of the worm, a
tissue where BLI-3 also resides, indicating a potential physical interaction between the two
(102). Despite the functional and spatial overlap of the DUOX BLI-3 and the heme-peroxidase
SKPO-1, questions remain regarding how this peroxidase and others function in a protective
role against pathogens.
Here, I characterized the other two immune-protective peroxidases, F09F3.5 and
F08F11.7, which I named HPX-2 and HPX-3 respectively for Heme Peroxidase 2 and 3. Using a
combination of RNA interference (RNAi) and CRISPR-Cas9 mediated gene inactivation
approcaches, I demonstrated that HPX-2 is important for protecting C. elegans against some,
but not all, pathogens.
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Results
RNAi of the putative peroxidases results in susceptibility to E. faecalis
To verify the protective role of the putative peroxidases against pathogen, I utilized RNA
interference experiments to knock down HPX-2 and HPX-3. The RNAi constructs were available
in the RNAi library (130), (131). The RNAi-treated animals were exposed to E. faecalis and
scored for survival over time. Consistent with previous findings, reduced expression of hpx-2
and hpx-3 resulted in a significant increase in pathogen susceptibility (Figure 3.1) (102).

Generation of CPRSR/Cas9 mutants of the putative peroxidases
To further study the function of the two putative peroxidases, I generated the truncated
mutant alleles of hpx-2 and hpx-3 through CRISPR-Cas9 mediated gene editing (Figure 3.2).
After PCR and sequencing for verification, one allele was obtained for each gene: hpx-2(dg047)
and hpx-3(dg048). The changes in DNA sequence are listed in Figure 3.3. Both alleles had
insertions and deletions (INDELS) at the 5’ end of the genes, resulting in the translated product
missing most of the predicted peroxidase domain and are therefore predicted loss-of-function
mutants (Figure 3.4). In addition to the CRISPR mutant, I was also able to obtain a nonsense
mutant allele of hpx-2 (hpx-2(gk252521)) from the Caenorhabditis Genetic Center (GCG)
(Figure 3.4). The EMS-generated mutant was backcrossed with the N2 strain six times to
eliminate background mutations.
After exposure to E. faecalis, I observed significant increases in the susceptibility of both
hpx-2 mutants (hpx-2(dg047) and hpx-2(gk252521)) to the pathogen which were more dramatic
than the RNAi-treated strain (Figure 3.6). However, in contrast with the RNAi result, no
significant changes in pathogen susceptibility from hpx-3(dg048) was observed (Figure 3.7). To
independently verify this result, I constructed one more allele of hpx-3 (hpx-3(dg049)) and
tested the strain’s pathogen sensitivity by exposing it to E. faecalis (Figure 3.5). The newly
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generated mutant allele of hpx-3 also did not exhibit pathogen sensitivity compared to the N2
strain (Figure 3.7). I hypothesized that the RNAi construct of hpx-3 used in the previous
experiments might have off-target effects, resulting in a false pathogen sensitivity phenotype.
Indeed, close examination of the sequence of the RNA construct revealed significant sequence
homology to the hpx-2 gene. It is likely that the hpx-3 RNAi construct had an off-target effect on
the hpx-2 gene causing a false positive result. Hence, I focused my project solely on HPX-2.
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Figure 3.1 Survival of worms on E. faecalis OG1RF following exposure to vector control
(VC) RNAi, (A) hpx-2 RNAi and (B) hpx-3 RNAi. Representative results from one experiment
with an n of approximately 90 worms for each condition are shown. Median survival and Pvalues are listed in Table 3.1 as experiment No.1 along with other biological replicates.
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Figure 3.2 Microinjection and screen for CRISPR mutants. Four single guide (sg) sequences
designed by WU CRISPR (http://crispr.wustl.edu) using the un-spliced sequence of the hpx-2 or
hpx-3 gene were cloned into pJW1219 (105). A mixture of four plasmid constructs were injected
into N2 worms at a concentration of 10 ng/µl each, and with 10 ng/µl of pJW1219-dpy-10 as a
co-CRISPR marker. Worms that displayed a roller or dumpy phenotype were then isolated for
genotyping to test for insertions and/or deletions (INDELs) in the targeted genes. Verified
CRISPR mutants were backcrossed with N2 to get rid of the dpy-10 mutation.
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Sequencing results of CRISPR mutants

WT
hpx-2 (dg047)

WT
hpx-3 (dg048)

5’ …CCA CCA AT - - - - - -TAACTGCAATAACCG ATTC… 3’
5’ …CCA CCA ATCCACCA - - - - - GCAATAACCG ATTC… 3’

5’ …. AGA AATTCTGGAGAG - - - - - - - - CAACAGGGTG GAGGT…3’
5’ … AGA AATTCTGGAGAGATTCTGGA - - - - - - - - - - - GAGGT…3’

hpx-2 (dg047) mutation results in a stop codon at down stream which produce 150aa
truncated version of P1 transcript 543 bp, truncated protein ~17.1 KD
Figure 3.3 DNA sequence of HPX-2 and HPX-3 CRISPR mutants. Blue letters indicate single

guide sequences, Grey and underlined letters indicate PAM sequences, red indicates the
changed sequence in the mutants.
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HPX-2 truncated mutants
1

158

696 718

N2

An_peroxidase domain
1

158 210

hpx-2(dg047)
1

133

hpx-2(gk252521)

Figure 3.4 Schematic representation of HPX-2 mutants. Wilde-type HPX-2 protein is
composed of 718 amino acids, with the predicted peroxidase domain at the C-terminus. hpx2(dg047) allele harbors an INDEL mutation at its N-terminus, resulting in a frameshift and
premature stop for protein translation. The predicted protein length is 210 amino acids. The hpx2(gk252521) allele has an amber mutation at its N-terminus, resulting in a truncated 133 amino
acid protein.
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R08F11.7 CRISPR mutants
1

189

752 773

N2

hpx-3 (dg048)

hpx-3 (dg049)

An_peroxidase domain
1

189 227

1

189 234

Figure 3.5 Schematic representation of HPX-3 mutants. Wild-type HPX-3 protein is
composed of 773 amino acids, with the predicted peroxidase domain at the C-terminus. hpx3(dg048) allele harbors an INDEL mutation at its N-terminus, resulting in a frameshift and
premature stop for the translated protein. The predicted protein length is 227 amino acids. The
hpx-3(dg049) allele has an has an INDEL mutation at its N-terminus, resulting in a frameshift
and premature stop for the translated protein. The predicted protein length is 234 amino acids.
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Figure 3.6 Survival of hpx-2 mutants on E. faecalis. Results from one representative
experiment with an n of approximately 90 worms for each condition are shown. Median survival
and P-values are listed in Table 3.1 as experiment No.1 along with other biological replicates.
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A

B

n.s.

n.s.

Figure 3.7 Survival of hpx-3 mutants on E. faecalis. Results from one representative
experiment with an n of approximately 90 worms for each condition are shown. Median survival
and P-values are listed in Table 3.1 as experiment No.1 along with other biological replicates.
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Hpx-2 mutants showed no general fitness defects
To ensure that the pathogen sensitivity phenotype of hpx-2 mutants was not due to an
impairment in general fitness of the worms, the mutants were tested for general defects in
fitness by measuring their longevity on live (Figure 3.8A) and heat-killed E. coli OP50 (Figure
3.8B). While both mutants showed slight longevity defects compared with the N2 strain on live
E. coli, there was no significant difference on heat-killed E. coli. The minor longevity defect of
the mutants on live E. coli OP50 might result from the slight pathogenicity of OP50 towards
worms as they age (132). Next, the mutants were tested on vancomycin inactivated E. faecalis
for survival. Although both mutant alleles showed significantly decreased survival on live E.
faecalis compared to N2 worms (Figure 3.6), the difference disappeared when worms were
exposed to E. faecalis inactivated by vancomycin treatment (Figure 3.9), suggesting live
bacteria were required for killing, and again indicating that the animals do not have a general
fitness defect.
In addition to wild-type survival rates on non-pathogenic bacteria, the hpx-2 mutants also
exhibited normal morphology and brood size compared to N2 wild type (Figure 3.10 and 3.11).
Overall, these data suggest that the loss of HPX-2 does not dramatically affect the fitness of the
worms.
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Figure 3.8 HPX-2 does
not contribute to the overall fitness of the worm on E. coli. Survival
Days elapsed
of N2 and hpx-2 mutants on (A) E. coli OP50 and (B) heat-killed E. coli OP50. Results from one
representative experiment with an n of approximately 90 worms for each condition are shown.
Median survival and P-values are listed in Table 3.1 as experiment No.1 along with other
biological replicates.
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Figure 3.9 HPX-2 does not contribute to the overall fitness of the worm on vancomycin
inactivated E. faecalis. Results from one representative experiment with an n of approximately
90 worms for each condition are shown. Median survival and P-values are listed in Table 3.1 as
experiment No.1 along with other biological replicates.
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Figure S3
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gk252521

200µm

Figure 3.10 hpx-2 mutant adults exhibit the same average size and morphology of N2

A

worms. Young adult worms of N2, hpx-2(dg047), and hpx-2 (gk252521) were collected and

N2

dg047

gk252521

observed under the light microscopy. Images are representative of >100 worms observed.
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Figure 3.11 hpx-2 mutants have comparable brood sizes compared to N2 worms. Phpx2(dg047) =0.2430,

n = 9. Error bars represent the SEM, and P-values were calculated via Student’s

paired t-test. Data are representative of three independent replicates.
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HPX-2 protects C. elegans from some but not all pathogens
To test if the pathogen susceptibility of the hpx-2 mutants is pathogen-specific, I
exposed them to multiple human pathogens including the fungal pathogen Candida albicans
SC5314 (Figure 3.12 A), Gram-positive pathogens Staphylococcus aureus NCTC8325 (Figure
3.12 B) and Corynebacterium diphtheriae NCTC12129 (Figure 3.12 C), and finally Gramnegative pathogens Pseudomonas aeruginosa PA14 (Figure 3.12 D), Escherichia coli O157:H7
Sakai (EHEC; Figure 3.12 E), and Salmonella enterica SL1344 (Figure 3.12 G). Interestingly,
hpx-2 mutants showed susceptibility to all the microbial pathogens tested except for the Gramnegative bacteria, raising the possibility that differences in microbial cell wall structure might
impact the phenotype observed with loss of hpx-2 (see Discussion).
hpx-2 mutants can be complemented with genomic DNA containing hpx-2 gene
To verify that HPX-2 is required for pathogen resistance, I complemented the mutant
strains with DNA containing the hpx-2 gene and subjected the animals to E. faecalis exposure.
Specifically, a 12-kb DNA fragment was PCR amplified from the genomic DNA of N2 worms.
The fragment was purified and injected into both mutant alleles at a concentration of 20 ng/µl
with Pmyo-2::mcherry (2 ng/µl) as a co-injection marker. When exposed to E. faecalis, the
complemented strains showed a significant increase in pathogen tolerance compared to the
parental strains, reaching a level of resistance similar to N2 (Figure 3.13 A and B). These data
collectively suggest that HPX-2 is required for resistance to many, but not all, pathogens
capable of infecting C. elegans.
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Figure 3.12 HPX-2 contributes to C. elegans resistance to some pathogens. Survival of N2
and hpx-2 mutants on (A) Candida albicans SC5314, (B) Staphylococcus aureus NCTC8325,
(C) Corynebacterium diphtheriae NCTC12129, (D) Pseudomonas aeruginosa PA14, (E)
Escherichia coli O157:H7 Sakai (EHEC), and (F) Salmonella enterica SL1344. Results from one
representative experiment with an n of approximately 90 worms for each condition are shown.
Median survival and P-values are listed in Table 3.1 as experiment No.1 along with other
biological replicates.
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Figure 3.13 Genomic hpx-2 complementation rescues the susceptibility to E. faecalis. (A)
Survival of N2, hpx-2(dg047) mutant, and its complemented strain on E. faecalis. (B) Survival of
N2, hpx-2(gk252521) mutant, and its complemented strain on E. faecalis. The hpx-2 mutants
are set as control. Results from one representative experiment with an n of approximately 90
worms for each condition are shown. Median survival and P-values are listed in Table 3.1 as
experiment No.1 along with other biological replicates.
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Discussion
In this chapter, I characterized a putative heme peroxidase, HPX-2, that contributes to
resistance to multiple pathogens in C. elegans. Base on previous work from our lab, I started my
investigation examining two putative peroxidases (HPX-2 and HPX-3) in C.elegans genome that
when knocked-down by RNAi render C. elegans susceptible to E. faecalis (102). Upon the
generation of CRISPR knockout mutants of these two peroxidases, I found that one of them,
HPX-3, does not contribute to pathogen resistance, and the RNAi results were likely due to offtarget effect. Hence, I have focused the remainder of my dissertation on HPX-2.
I first demonstrated that loss of HPX-2 did not affect the overall fitness of the worms as
reflected by the normal overall morphology, brood size, and survival rate on E. coli compared to
N2 strain. In contrast, the two previously identified peroxidases, SKPO-1 and MLT-7, both had
impacts on the morphology of C. elegans when knocked down or mutated (29, 102).
Specifically, the SKPO-1 mutant exhibited an incomplete penetration of dumpy phenotype (102).
It also exhibited a significantly smaller brood size and slower growth compared to the N2 strain
(102) (unpublished data). MLT-7, on the other hand, exhibits a severe blistered phenotype when
mutated because of its essential role in cuticle cross-linking (29). Overall, the data suggest that
HPX-2 is not likely to be heavily involved in the morphogenesis of the worm cuticle (discussed in
more detail in Chapters 4 and 5).
Next, I showed that HPX-2 protects worms from Gram-positive bacteria and fungi, but
not Gram-negative bacteria. The pathogens I tested included C. albicans SC5314,
Staphylococcus aureus NCTC8325, Corynebacterium diphtheriae NCTC12129, Pseudomonas
aeruginosa PA14, Escherichia coli O157:H7 Sakai (EHEC), and Salmonella enterica SL1344.
The reasons I chose those microbes are as follows: First, they represent a wild-range of
pathogenic microbes spanning from prokaryotes to eukaryotes. Second, they are all well
characterized human pathogens with important clinical relevance. Last but not least, they have
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been shown to be pathogenic to C. elegans following colonization of the intestines. As to why
hpx-2 mutants were more susceptible to fungal and Gram-positive pathogen but not the Gramnegative, I hypothesize that it is because of the difference in their cell wall structure. Yeast and
Gram-positive bacteria have thick and hard to disrupt cell walls compared to Gram-negatives.
As mentioned in the introductory chapter, the pharyngeal grinder of the worm disrupts most
bacteria through chemical and physical mechanisms, serving as the first defense against
intestinal colonization. Given the fact that HPX-2 is produced in the pharynx of the worm (see
next chapter for detail), it might play an important role in assisting the pharyngeal disruption of
microbial cell wall during feeding. It could also be that different pathogens have different modes
of killing, and the mechanism of HPX-2 action might be protective against some modes but not
others. To lessen this possibility, I made sure that I was using pathogens with similar infection
sequelae. For all these pathogens, intestinal colonization is a prerequisite for infection.
Specifically, I used the slow-killing assay to assess P. aeruginosa pathogenesis, which has
been shown to require intestinal colonization as compared to fast-killing, which is toxin
mediated. Additionally, I used the shiga toxin-negative strain of EHEC to infect C. elegans,
which also requires intestinal colonization for killing.
In conclusion, I report a putative peroxidase, HPX-2, protects C. elegans from fungal and
Gram-positive pathogen infection, and that loss of HPX-2 does not affect overall fitness of the
worm. This highlights the immune-specific function of peroxidases in the worm.
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Chapter 4: HPX-2 functions in pharynx and hypodermis as a putative peroxidase for
pathogen resistance

56

Introduction
In Chapter 3, I showed that HPX-2 provides protection from many, but not all pathogen
infections. In order to further study the function of HPX-2 in innate immune protection, I decided
to investigate its localization and enzymatic function.
The only functional NOX/DUOX, BLI-3, was first shown to be localized to the hypodermis
using immune-staining, which is consistent with its function in cuticle cross-linking (28). Later, a
study from our lab showed that BLI-3 might also be present in the intestine and involved in
pathogen resistance since intestinal-specific RNAi knockdown of BLI-3 resulted in increased
susceptibility to E. faecalis (99). More recently, through the construction of a BLI-3::mCherry
transgene, BLI-3 was localized to the pharynx in addition to the intestine and the hypodermis
(100). It was also shown that BLI-3 is involved in protecting worms from C. albicans infection in
addition to E. faecalis infection, although the amount and pattern of BLI-3 localization did not
change upon exposure to these pathogens (101).
Given that DUOXs often pair with peroxidases for their function, I postulated that
peroxidases that functionally interact with BLI-3 are likely to be in one or more of the tissues that
harbor BLI-3. Indeed, a previous study from our lab demonstrated that SKPO-1, another
immune-protective peroxidase, localizes to the hypodermis (102). Considering that HPX-2 is
also likely to functionally interact with BLI-3, I tested the hypothesis that it has a similar
expression/ localization pattern and is likely to be found in pharynx, gut and/or hypodermis.

57

Results
HPX-2 localizes to pharynx and hypodermis of the worms
To functionally localize HPX-2, I conducted tissue-specific RNAi to knock down hpx-2 in
the intestine or hypodermis and measured the worms’ susceptibility to E. faecalis. I observed
that intestinal RNAi did not affect pathogen susceptibility, whereas hypodermal RNAi resulted in
a slight but significant decrease, suggesting that HPX-2 might be present in the hypodermis and
contribute to pathogen resistance in this tissue (Figure 4.2 A and B).
To directly visualize the expression of HPX-2, I created a partial translational fusion of
HPX-2 to GFP. Specifically, a 4-kb region containing the upstream sequence and the first two
exons of the hpx-2 gene was cloned to generate a fusion with GFP (Figure 4.3 A). The construct
was injected into the worms at a concentration of 50 ng/µl with pRF4 (20 ng/µl) as a co-injection
marker (133). The resulting extrachromosomal array was then integrated into the chromosome
by the TMP/UV method (106). I initially looked at the stable transgenic worms at different
development stages but did not observe GFP expression in the majority. Occasionally (in about
~1% of the worms), I observed a green fluorescent stripe extending from the distal bulb of the
pharynx to the anterior of the buccal cavity (Figure 4.3 B). I postulated that the expression level
might be too low to detect. In fact, expression data from Wormbase and our RNA-seq data (see
below) indicate that the overall expression level of hpx-2 gene is extremely low at the whole
worm level but increases significantly upon entry into dauer. When I subsequently analyzed
dauer animals using confocal microscopy, I observed weak expression of hpx-2::GFP in the
distal bulb of the pharynx in nearly all the animals (Figure 4.3 C). At higher magnification, the
localization pattern was most consistent with expression in the gland cells (Figure 4.3 D) (134).
Again, around 1% of the worms showed the striped expression pattern, resembling the structure
called the “process” that extends from the dorsal g1 gland cell to the anterior of the buccal cavity
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(Figure 4.3 E). Interestingly, the process functions in transporting excreted material from the
gland cell to the pharyngeal lumen (135, 136). Overall, these results indicate that hpx-2 is
expressed in the epidermis and pharynx.
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Figure 4.2. HPX-2 functionally localizes to the hypodermis of the worm. (A) Survival of the
intestinal RNAi strain on E. faecalis following exposure to of hpx-2 or VC control RNAi. (B)
Survival of the hypodermal RNAi strain on E. faecalis following exposure to hpx-2 or VC control
RNAi. Representative results from single experiments with an n of approximately 90 worms for
each condition are shown. Median survival and P-values along with replicates are listed in S8
Table as experiment No.1.
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HPX-2 contributes to cuticle integrity
A functional role in cuticle biogenesis was demonstrated for some of the previously
studied heme peroxidases and loss-of-function mutations sometimes caused abnormal cuticle
morphology. For example, MLT-7, was shown to function in conjunction with BLI-3 to cross-link
the cuticular collagens during the molting process. Loss of MLT-7 resulted in a blistered
phenotype due to incomplete cross-linking of these extracellular matrix proteins (29). Another
immune protective peroxidase previously studied by our lab, SKPO-1, has an incomplete
penetrance of dumpy phenotype when mutated, again suggesting a role in cuticle generation
(102).
Given the pathogen sensitivity phenotype that resulted from hypodermal-specific RNAi
(Figure 4.2 B), I postulated that HPX-2 might play a role in the generation and/or structural
integrity of the cuticle. However, unlike the mlt-7 or skpo-1 mutants, the hpx-2 animals displayed
normal morphology as observed under the dissecting microscope (Figure 3.10). To test for more
subtle defects, cuticle integrity was measured by testing how permeable the animals were to a
DNA dye (137). Specifically, I exposed the worms to the DNA staining agent Hoechst 33258
and scored how many exhibited nuclear staining of their hypodermal cells, evidence of dye
penetration (Figure 4.4 A). While about 15% of N2 animals showed evidence of nuclear
staining, 25-30% of the HPX-2 mutants displayed this phenotype, indicative of some loss of
cuticle integrity (Figure 4.4 B).
Even though the loss of HPX-2 did not affect the low-resolution morphology of the worm,
I observed that some of the strains generated by injection of higher amounts of the hpx-2
complementation construct displayed a slightly dumpy or partial roller phenotype. These
animals were also more sensitive to E. faecalis than wild-type or hpx-2 mutant animals (Figure
4.5 A and B). I hypothesized that overexpression of hpx-2 might be contributing to these
phenotypes. The level of hpx-2 expression in the different strain backgrounds was measured,
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showing a correlation between higher mRNA levels and hyper-sensitivity to E. faecalis (Figure
4.4 C). The results indicate that too much as well as too little HPX-2 cause cuticle defects and
sensitivity to the pathogen.
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Figure 4.4. The cuticle defect of hpx-2 mutants. (A) Hoechst staining of N2, hpx-2(dg047)
and hpx-2(gk252521) worms. Worms with stained nuclei were scored as positive. Images
presented are representative of ~300 worms observed. (B) Quantification of Hoechst positive
worms in N2, hpx-2(dg047) and hpx-2(gk252521) worms. Compared with N2, both mutants had
significant higher level of Hoechst staining (Phpx-2(dg047)=0.0022, Phpx-2(gk252521)=0.033). The graph
was generated from 3 independent experiments (n=30). Error bars represent SEM.
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Figure 4.5. Overexpression of HPX-2 results in susceptibility to E. faecalis. (A) Survival of
N2, hpx-2(dg047), and the strain overexpressing hpx-2 in hpx-2(dg047) background on E.
faecalis OG1RF. (B) Survival of N2, hpx-2(gk252521), and the strain overexpressing hpx-2 in
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(gk252521) OE strains compared to N2. The average gene expression of biological triplicates is
shown, and the error bars represent SEM.
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HPX-2 limits colonization by E. faecalis, but has no effect on P. aeruginosa
I next examined the functional relevance of the pharyngeal presence of HPX-2,
predicting it might contribute to this organ’s structural integrity. The apical surface of the
pharyngeal lumen is lined with cuticle, which connects to the cuticle of the epidermis.
Specialized projections of the pharyngeal cuticle can form structures, such as the teeth-like
formations found in the terminal bulb (grinder) that are thought to contribute to mechanical
microbial disruption (135). HPX-2 was found to be expressed in the gland cells of the pharynx
(Figure 4.3 B-E), and one hypothesis for its function is aiding cuticle development/remodeling of
this organ following excretion into the pharyngeal lumen. I hypothesized that loss of hpx-2 might
weaken the pharynx, resulting in less disruption of ingested bacteria and increased intestinal
colonization by pathogens. To test this hypothesis, I exposed L4 worms to a strain of E. faecalis
OG1RF that constitutively expresses GFP and measured the level of intestinal colonization by
both fluorescence microscopy and CFU plating (115). At Day 2 of infection, I observed a higher
level of intestinal colonization in the hpx-2 mutant strains, indicated by higher fluorescent
intensity and CFU counts (Figure 4.6 A and B). In contrast, when I exposed worms to a P.
aeruginosa PA14 strain expressing dsRed (117), I did not observe any significant differences
between the N2 strain and the mutants in either fluorescent intensity or CFUs (Figure 4.6 C and
D), which is consistent with the observation that N2 and hpx-2 mutants are equally susceptible
to P. aeruginosa (Figure 3.12 D). Although the hpx-2 mutant might have impaired grinding
capability, no obvious structural abnormalities of the pharynx were observed when examined by
light microscopy (Figure 4.7 A). In addition, the pumping rate of the worms was not significantly
affected (Figure 4.7 B). Together, these results suggest that HPX-2 functions in the pharynx to
reduce intestinal colonization by some pathogens, possibility through the structural
reinforcement of the grinder or other parts of the pharyngeal cuticle.
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The catalytic activity of HPX-2 is required for resistance to pathogens
Sequence comparison of HPX-2 to other peroxidases indicates that HPX-2 possesses
all the conserved residues required for peroxidase catalytic activity, including the distal histidine
(H240 ), the catalytic arginine (R372), and the proximal histidine (H240 ) (reviewed by (138)). On the
other hand, similar to BLI-3 and MLT-7, HPX-2 lacks the covalent heme-binding residues that
are conserved in mammalian peroxidases (138). However, this does not rule out the possibility
of non-covalent heme binding since both human DUOX1 and DUOX2 lack the conserved
residues but still bind heme weakly (139, 140). Thus, I hypothesize HPX-2 has peroxidase
activity.
To test this hypothesis, I used an Amplex red assay that measures pathogen-stimulated
H2O2 release in the hpx-2 mutant strain hpx-2(dg047) (99) (98). In previous work, a skpo-1
mutant was characterized as releasing more H2O2 than N2 when exposed to the pathogen E.
faecalis, presumably because less H2O2 was being consumed (102). In contrast, I found H2O2
levels generated by the hpx-2(dg047) mutant were comparable to N2 following exposure to E.
faecalis (Figure 4.8). While this could be because HPX-2 possesses little peroxidase activity, it
also could be due to its low expression level or a lack of activity under these conditions.
To directly test the activity of HPX-2 using in vitro assays, I attempted to express the
HPX-2 recombinant protein in E. coli expression system. Specifically, the cDNA of hpx-2
encoding full-length protein excluding the signal peptide of HPX-2 was cloned into expression
vector pET-29b (+) and transformed into in E. coli BL21 (DE3). Unfortunately, upon induction, I
could not detect any expression of the recombinant protein through SDS-PAGE and Coomassie
staining. Although a weak band can be detected by Western blotting using anti-His antibody, the
amount was too little to be used in any biochemical assays.
To further examine the possible contribution of HPX-2’s peroxidase activity to pathogen
resistance, I analyzed a strain harboring a single amino acid mutation that changes an active
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site residue of the peroxidase domain. Specifically, the catalytic arginine residue was
substituted to alanine through CRISPR-Cas9 mediated mutagenesis (Figure 4.9 A). The
catalytic arginine is conserved throughout peroxidase–cyclooxygenase superfamily, and the
substitution of the arginine to alanine abolishes peroxidase activity (141, 142). Like the hpx-2
deletion mutants, this point mutant exhibited increased sensitivity to E. faecalis, suggesting that
the catalytic activity of the peroxidase active site of HPX-2 is required for the pathogen
resistance phenotype (Figure 4.9 B).
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Figure 4.8 Amplex red assay of N2 and hpx-2(dg047) mutant. Worms were grown to L4
stage and exposed to E. coli OP50 or E. faecalis OG1RF for 16 hours at 25°C. The amount of
H2O2 was then measured with or without exposure to 80mM diphenyleneiodinium chloride (DPI).
Error bars represent the SEM and P values were calculated via Student’s paired t-test. Data is
representative of three independent replicates.
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Table 4.1 Median survival and P-values in killing assays
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Discussion
In this chapter, I demonstrated that HPX-2 is produced in the pharynx and hypodermis of
the worms, as well as its function in cuticle strengthening and pathogen resistance.
Pharyngeal function of HPX-2
In the pharynx, the expression pattern of hpx-2::GFP resembles that of the gland cell
reporter gene B02807::GFP (143, 144), with expression being observed in the process that
extends from the terminal bulb to the posterior end of the buccal cavity. There are two groups of
gland cells, three g1 cells and two g2 cells, located at the distal bulb of the pharynx. The gland
cells are thought to secrete vesicles containing enzymes that function in the digestion of
microbial food and aid in cuticle formation during the molting process (136). Specifically, during
the feeding process, small vesicles are transported from the g1 cells through the process to the
secretory ducts to aid digestion. During molting, much larger vesicles are transported through
the process and the enzymes they contain are thought to be involved in the tearing down and
building up of the cuticle, a critical remodeling process (136).
I postulate that HPX-2 is protective by virtue of it being secreted into the pharyngeal
lumen by gland cells to aid in cuticle remodeling of the pharynx during development. A properly
developed pharyngeal cuticle is likely necessary for effective disruption of microbes during the
digestive process. Because Gram-positive bacteria and fungi like C. albicans have thicker,
harder-to-disrupt cell walls, this model could explain why the hpx-2 mutants were colonized
more efficiently by, and were more susceptible to, these pathogens compared to Gram-negative
bacteria (Figures 3.12). The cell envelope of Gram-negatives is comprised of two membranes,
but only a thin layer of peptidoglycan, rendering these organisms easier to disrupt by
mechanical means (Reviewed in (145)), and may explain why the hpx-2 mutants were not more
susceptible to them.
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In previous studies examining staged animals, significant levels of hpx-2 expression
were only observed during dauer (146). Using lines expressing an HPX-2::GFP fusion, I also
detected expression during dauer in most animals examined (Figure 4.3). However, I did not
observe GFP expression in the vast majority of animals at other stages (L1-L4 and adult) and
during pathogen exposure. Using the HPX-2::GFP line, I occasionally saw expression in the
pharynx of animals examined at the L4 to young adult stages and speculate that they might be
animals undergoing molting. Based on all these observations, I speculate that hpx-2 is
expressed during times of cuticle remodeling, including the larval molts and dauer formation.
Additionally, HPX-2 may be subject to mechanisms of post-transcriptional regulation that would
not necessarily be elucidated by these approaches focused on transcriptional regulation.
Hypodermal function of HPX-2
Peroxidases play important roles in cuticle bio-generation process and loss-of-function
mutants frequently exhibit morphological defects. Mutations in MLT-7 or the peroxidase domain
of BLI-3 result in severe blister phenotypes (29, 147). skpo-1 mutants have a partially penetrant
dumpy phenotype (102). Loss of HPX-2 did not result in a morphological phenotype observable
by light-microscopy. However, the increase in cuticle permeability, as evidenced by Hoechst
staining, indicates some perturbation of the cuticle. Additionally, overexpression of hpx-2, by
injection of higher concentrations of the transgene, resulted in some dpy and rol animals, again
indicative of HPX-2 playing a role cuticle biogenesis. Tissue-specific RNAi knock-down of hpx-2
in the hypodermis resulted in a weak susceptibility phenotype. Collectively, these data suggest
that hpx-2 is expressed and plays an infection-protective role in the hypodermis, though
expression of our HPX-2::GFP transgene was not detectable in this tissue.
How might a cuticle impaired by lack of HPX-2 translate into susceptibility to pathogen?
First of all, it is important to note that not all cuticle defects alter sensitivity. For example, mlt-7
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mutations and bli-3 peroxidase domain mutations result in severe blistered phenotypes, with no
concomitant increase in pathogen susceptibility (99, 102) Interestingly, a recent study showed
that disruption of some, but not all, aspects of cuticle structure triggers the activation of multiple
stress response pathways (148). Specifically, it was discovered that disruption of the annular
furrows activates detoxification, osmolyte, and most importantly, antimicrobial responses. In
regard to HPX-2, I hypothesize that structural disturbance of the hypodermal cuticle perturbs
signal transduction related to innate immune and/or stress responses. However, a precise
understanding will require more detailed knowledge of exactly how HPX-2 modulates cuticle
structure.
In conclusion, I report the characterization of a peroxidase, HPX-2, that functions
protectively against multiple pathogen infections in C. elegans. The data suggest that HPX-2
contributes in a peroxidase-dependent manner either directly, by modulating the cuticular
structure, and/or indirectly, by affecting downstream innate immune and/or stress responses
pathways. While further investigations will be required to elucidate the precise mechanism, our
findings highlight the complexity and multiple factors involved in pathogen defense.
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Chapter 5 Transcriptome analysis reveals that hpx-2 mutant misregulates genes for
cuticle synthesis and has a stronger response to infection.
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Introduction
In the last two chapters, I demonstrated that HPX-2 is expressed in the pharynx and
hypodermis of the worm and functions in pathogen resistance. More specifically, it reduced
intestinal colonization of Gram-positive bacteria. I also showed that over-expression of HPX-2
not only resulted in pathogen susceptibility comparable to hpx-2 mutants, but also caused
abnormal body morphology, i.e. occasional dumpy and roller phenotypes. These findings
strongly suggest that HPX-2 plays roles in pathogen resistance and cuticle biogenesis.
However, the exact mechanisms and the pathways by which HPX-2 operates in these two
processes are not clear. Furthermore, the loss of HPX-2 did not result in any physiological
changes in the animal under non-pathogenic conditions, making it hard to pin-point the functions
of HPX-2 during normal development of the worms. Thus, I decided to utilize RNAseq analysis
as an un-biased and highly sensitive method to measure the changes in gene expression
profile, which reflects the overall physiology of the animal. I also decided to examine hpx-2
animals exposed to the pathogen E. faecalis to determine if the innate immune response was
significantly different than that of the N2 reference strain. I believe that investigating the global
transcriptional changes in both the hpx-2 mutant and the N2 wild-type, under non-pathogenic
and pathogenic conditions might uncover some insights into the mechanisms and pathways by
which HPX-2 influences pathogen susceptibility and cuticle development.
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Results
Transcriptome analysis reveals that hpx-2 mutant misregulates genes for cuticle
syntheses.
To better understand how the loss of HPX-2 affected the global gene profile of the worm,
I examined the differences in gene expression of a hpx-2 mutant (hpx-2(dg047)) compared to
the N2 reference strain under both non-pathogenic (exposed to E. coli OP50) and pathogenic
(exposed to E. faecalis OG1RF) conditions.
First, under the non-pathogenic condition (exposed to E. coli OP50), there were a total of
69 genes that were significantly differentially expressed in the mutant, with 34 genes upregulated and 35 down-regulated. 21 of the affected genes encode structural constituents of the
cuticle, including 17 col genes, 3 dpy genes (dpy-3, dpy-4, and dpy-5), and 2 rol genes (rol-1
and rol-6). GO term analysis further revealed an enrichment of genes that are involved. All of
them are downregulated, suggesting a perturbed cuticle biogeneration process upon the loss of
HPX-2 (Table 5.1). In addition, genes involved in locomotion are also affected, which could
explain the partial roller and dumpy phenotype in the HPX-2 overexpression strains examined in
chapter 4 (Table 5.1).
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Category Term
BP
BP
BP
BP
BP
BP
BP
BP
BP
BP
BP
BP
BP
BP
BP
BP
BP
BP
BP
BP
BP
BP
CC
CC
CC
CC
MF
MF
MF
MF

hpx-2(dg047) on OP50 vs. N2 on OP50
Count

body morphogenesis
locomotion
collagen and cuticulin-based cuticle
development
molting cycle, collagen and cuticulin-based
cuticle
cellular response to osmotic stress
UV protection
single-organism transport
molting cycle process
cuticle development
epithelial cell development
intein-mediated protein splicing
cuticle development involved in collagen and
cuticulin-based cuticle molting cycle
response to osmotic stress
response to oxidative stress
cell-cell signaling
nematode larval development
MAPK cascade
defense response
regulation of multicellular organism growth
nematode male tail tip morphogenesis
segment polarity determination
protein catabolic process
collagen trimer
cell periphery
collagen and cuticulin-based cuticle
extracellular matrix
extracellular region
structural constituent of cuticle
structural constituent of collagen and
cuticulin-based cuticle
MAP kinase activity
hydrolase activity, acting on carbon-nitrogen
(but not peptide) bonds

32
39

Fold
P-value
Enrichment
6.6
8.30E-18
3.5
5.30E-13

11

12.4

1.50E-08

14
5
5
4
4
4
4
3

6
42.6
39.9
73
30.1
26.9
21.3
42.6

4.80E-07
4.30E-06
5.70E-06
1.50E-05
2.80E-04
4.00E-04
8.10E-04
2.10E-03

3
3
5
3
27
3
5
3
4
2
5
35
6

42.6
38.3
8.5
34.8
1.7
16.7
5.3
13.7
6.6
63.9
4.1
26
32.3

2.10E-03
2.60E-03
2.70E-03
3.10E-03
3.80E-03
1.30E-02
1.40E-02
2.00E-02
2.20E-02
3.10E-02
3.30E-02
5.50E-40
8.80E-07

5
10
41

58.7
3.9
30

1.00E-06
9.40E-04
2.30E-51

7
3

39.2
28.4

1.50E-08
4.70E-03

2

18.9

9.90E-02

Table 5.1: GO Term analysis of genes that changed upon loss of HPX-2 (hpx-2(dg047))
compared to N2, when exposed to E. coli OP50. Genes that are involved in cuticle
generation and body morphogenesis are enriched in the hpx-2 mutant. BP: Biological
Processes; MF: Molecular Functions. CC: Cellular Component.
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I next analyzed gene expression changes in a hpx-2 mutant after 16 hours of exposure
to E. faecalis OG1RF compared to N2 strain. I chose this early time point because the worms
show limited damage and thus the indirect effects should be smaller than later during infection.
Under these conditions, there were a total of 125 genes that were differentially expressed in the
mutant (72 up-regulated and 53 down-regulated) with 106 of them unique to the pathogenic
condition. Interestingly, genes involved in cuticle generation were again significantly altered, and
with a greater enrichment score (Table 5.2). Compared to the 21 genes under nonpathogenic
conditions, a total of 41 cuticle genes were affected and up-regulated. In addition to the
increased changes in cuticle structural genes, there was an enrichment of genes encoding
proteins involved in defense response to Gram-positive bacteria (Table 5.2). These include 4
out of 10 lysozyme genes (lys-1, lys-2, lys-3, and lys-7), and f53a9.8, which is involved in
defense response against Gram-positive bacteria and expressed in the intestine (144, 149,
150). Additionally, genes that are involved in general innate immune response, response to
Gram-negative, and xenobiotic stress response were also enriched, although there was some
overlap of genes in those groups (Table 5.2).
In order to verify the RNAseq result, I performed qRT-PCR on 10 genes that are
changed in expression in the hpx-2 mutant compared to N2 under the pathogenic condition. The
log2 change in gene expression from qRT data was then plotted against the RNAseq data to
evaluate their correlation (Figure 5.1). Trend line analysis revealed that R2 > 0.9, suggesting
consistency between the RNAseq data and the qRT-PCR data.
Finally, in order to compare the genes that were differentially expressed under the nonpathogenic compared to the pathogenic condition, I plotted the gene lists against each other
(Figure 5.2). In general, there was a close correlation between the two conditions, meaning
genes that were differentially expressed under one condition were also changed in the other,
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although the degree of changes was sometimes different. In addition, the degree of fold-change
was quite small with majority of the log2 changes less than 2 (Figure 5.2).
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hpx-2(dg047) on OG1RF vs. N2 on OG1RF
Category Term
Count
BP
BP
BP
BP
BP
BP
BP
BP
BP
BP
BP
BP
BP
BP
BP
BP
CC
CC
CC
CC
CC
MF
MF
MF
MF
MF
MF
MF
MF
MF
MF
MF
MF
MF
MF
MF
MF
MF
MF

innate immune response
metabolic process
response to xenobiotic stimulus
defense response to Gram-negative
bacterium
defense response
defense response to Gram-positive bacterium
response to nematicide
flavonoid glucuronidation
flavonoid biosynthetic process
MAPK cascade
response to osmotic stress
transmembrane transport
proteolysis involved in cellular protein
catabolic process
oxidation-reduction process
monocarboxylic acid transport
response to gamma radiation
intracellular membrane-bounded organelle
extracellular region
lysosome
collagen trimer
membrane raft
ATPase activity, coupled to transmembrane
movement of substances
iron ion binding
steroid hydroxylase activity
carbohydrate binding
ATPase activity
efflux transmembrane transporter activity
heme binding
transferase activity, transferring hexosyl
groups
oxidoreductase activity, acting on paired
donors, with incorporation or reduction of
molecular oxygen
structural constituent of cuticle
monooxygenase activity
glucuronosyltransferase activity
MAP kinase activity
ATP binding
oxidoreductase activity
nutrient reservoir activity
protein serine/threonine kinase activity
cysteine-type endopeptidase activity
83

P-value

21
32
5

Fold
Enrichment
5.7
2.6
54.2

9
10
6
4
6
6
4
3
11

9.3
7.2
13
31.6
7.3
7.3
15.1
26
2.3

5.00E-06
9.80E-06
8.70E-05
2.30E-04
1.30E-03
1.30E-03
2.20E-03
5.50E-03
2.00E-02

4
11
2
2
7
11
5
7
4

6
1.8
21.7
19.3
6.1
3.4
6.9
4.1
5.6

2.90E-02
7.60E-02
8.80E-02
9.80E-02
9.40E-04
1.50E-03
5.90E-03
7.10E-03
3.30E-02

7
8
5
12
7
3
8

7
8
5
12
7
3
8

6.00E-05
6.50E-04
1.30E-03
1.50E-03
1.70E-03
2.30E-03
3.50E-03

6

6

4.10E-03

6
8
6
5
3
20
11
2
8
3

6
8
6
5
3
20
11
2
8
3

4.50E-03
5.60E-03
7.30E-03
9.90E-03
1.10E-02
3.20E-02
4.30E-02
7.40E-02
7.90E-02
9.20E-02

4.80E-10
8.00E-07
1.10E-06

MF

monocarboxylic acid transmembrane
transporter activity

2

2

9.80E-02

Table 5.2: GO Term analysis of genes that changed upon loss of HPX-2 (hpx-2(dg047))
compared to N2, when exposed to E. faecalis OG1RF.Genes that are involved in cuticle
generation and body morphogenesis are further enriched in the hpx-2 mutant. Additionally,
defense response genes are enriched as well. BP: Biological Processes; MF: Molecular
Functions. CC: Cellular Component.
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Figure 5.1 qRT-PCR validation of 10 selected genes differentially expressed in the RNAseq analysis of hpx-2(dg047) to N2 on E. faecalis. Mean log2 (fold change) determined in
three independent qRT-PCR were plotted against the log2 (fold change) from the RNAseq
experiments.
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Figure 5.2. Scatter plot of genes changed in hpx-2(dg047) animals, as compared to N2
animals, when either exposed to E. coli (x-axis) or E. faecalis (y-axis). Values of 10 or -10
indicate expression level under one condition was 0 RPKM.
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Transcriptome analysis reveals a stronger response in hpx-2 mutant upon infection.
To understand the general response of the worms when exposed to E. faecalis, I
examined the gene profiles of animals exposed to E. faecalis as compared to those exposed to
OP50. Not surprisingly, there were a great number of genes that were differentially expressed
when exposed to pathogen, suggesting a global reaction that involves in host defense. In N2, a
total of 4217 genes (2560 up-regulated and 1657 down-regulated) were significantly
differentially expressed, many of which were consistent with previously published data (79). GO
term analysis revealed a long list of genes that are involved in multiple physiological process,
with innate immune response being the most significant one (Table 5.3). In the hpx-2 mutant,
however, an even larger number of genes were significantly differentially expressed: 8313
genes in total with 4255 of them up-regulated and 4058 down-regulated (Table 5.4). To examine
the relationship between the two sets of genes, genes that were significantly expressed under at
least one condition were plotted (Figure 5.3). Compared to the N2 strain, the hpx-2 mutant had
similar, but stronger responses to the pathogen, contributing to the larger number of genes with
significant changes in expression under the pathogenic condition. In summary, we conclude that
the loss of hpx-2 results in a stronger response to infection, perhaps reflecting the increased
microbial load experienced by this strain during E. faecalis infection (Figure 4.6 A and B).
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Category Term
BP
BP
BP
BP
BP
BP
BP
BP
BP
BP
BP
BP
BP
BP
BP
BP
BP
BP
BP
BP
BP
BP
BP
BP
BP
BP
BP
BP
BP
BP
BP
BP
BP
BP
BP
BP
BP
BP
BP
BP

N2 on OP50 vs. N2 on OG1RF
Count

innate immune response
oxidation-reduction process
metabolic process
flavonoid glucuronidation
flavonoid biosynthetic process
cell projection organization
nonmotile primary cilium assembly
defense response to Gram-negative
bacterium
cilium assembly
dauer entry
steroid hormone mediated signaling pathway
single-organism transport
fatty acid metabolic process
defense response to Gram-positive bacterium
response to xenobiotic stimulus
lipid metabolic process
epithelial cell development
defense response
transcription, DNA-templated
transmembrane transport
fatty acid beta-oxidation
positive regulation of transcription from RNA
polymerase II promoter
homophilic cell adhesion via plasma
membrane adhesion molecules
cell-matrix adhesion
regulation of transcription, DNA-templated
negative regulation of transcription from RNA
polymerase II promoter
carbohydrate metabolic process
collagen and cuticulin-based cuticle
development
neuron differentiation
molting cycle process
regulation of neuron differentiation
response to nematicide
cuticle development
vulval location
heme transport
interneuron axon guidance
nervous system development
one-carbon metabolic process
intraciliary transport
sphingolipid metabolic process
88

P-value

70
74
120
21
21
10
11

Fold
Enrichment
3.3
2.1
1.7
4.4
4.4
8.3
5

17
10
12
35
5
11
10
5
26
7
17
54
41
6

3
4.8
3.7
1.9
10.7
3.5
3.8
9.4
1.9
4.4
2.1
1.4
1.5
4.3

1.10E-04
1.30E-04
3.00E-04
5.00E-04
5.80E-04
8.70E-04
1.00E-03
1.10E-03
3.50E-03
4.00E-03
6.30E-03
9.80E-03
1.10E-02
1.10E-02

20

1.9

1.10E-02

5
4
67

5.4
7.5
1.3

1.10E-02
1.30E-02
1.40E-02

13
19

2.2
1.8

1.40E-02
1.60E-02

15
5
5
4
4
5
5
3
3
11
4
4
6

2
4.7
4.4
5.5
5.5
4
4
9
9
2.1
4.6
4.6
2.9

1.70E-02
1.90E-02
2.30E-02
3.20E-02
3.20E-02
3.40E-02
3.40E-02
3.90E-02
3.90E-02
3.90E-02
5.10E-02
5.10E-02
5.20E-02

3.30E-19
7.40E-10
4.90E-09
2.00E-08
2.00E-08
6.80E-07
3.60E-05

BP
BP
BP
BP
BP
BP
BP
BP
BP
BP
BP
BP
CC
CC
CC
CC
CC
CC
CC
CC
CC
CC
CC
CC
CC
CC
CC
CC
MF
MF
MF
MF
MF
MF
MF
MF
MF
MF
MF
MF
MF
MF

anion transport
macromolecule glycosylation
MAPK cascade
lipid storage
dephosphorylation
fatty acid beta-oxidation using acyl-CoA
dehydrogenase
cell wall macromolecule catabolic process
proteolysis involved in cellular protein
catabolic process
protein localization to ciliary transition zone
unsaturated fatty acid biosynthetic process
intraciliary retrograde transport
regulation of backward locomotion
collagen trimer
intracellular membrane-bounded organelle
extracellular region
membrane raft
ciliary basal body
extracellular space
BBSome
cilium
lysosome
cell projection
gut granule membrane
intraciliary transport particle B
apical plasma membrane
proteinaceous extracellular matrix
nonmotile primary cilium
peroxisome
structural constituent of cuticle
monooxygenase activity
iron ion binding
oxidoreductase activity, acting on paired
donors, with incorporation or reduction of
molecular oxygen
oxidoreductase activity
heme binding
transferase activity, transferring hexosyl
groups
steroid hydroxylase activity
glucuronosyltransferase activity
sequence-specific DNA binding
cholinesterase activity
carbohydrate binding
transcription factor activity, sequence-specific
DNA binding
RNA polymerase II regulatory region
sequence-specific DNA binding
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9
5
5
56
8

2.2
3.4
3.3
1.2
2.2

5.20E-02
5.40E-02
6.30E-02
6.80E-02
7.10E-02

5
3

3.1
6.4

7.10E-02
7.40E-02

8
3
3
3
3
40
27
49
20
9
35
5
10
12
13
3
4
9
6
9
6
40
28
31

2.1
5.6
5.6
5.6
5.6
3.6
3.6
2.3
4.3
6.7
2.1
11.1
3.2
2.5
2
9.3
5.2
2.2
2.9
2
2.5
3.3
4.1
3.8

8.90E-02
9.50E-02
9.50E-02
9.50E-02
9.50E-02
3.40E-12
1.40E-08
7.70E-08
8.10E-08
2.70E-05
4.80E-05
5.00E-04
3.10E-03
7.20E-03
3.00E-02
3.60E-02
3.70E-02
4.70E-02
5.10E-02
8.40E-02
9.40E-02
2.40E-11
2.30E-10
2.40E-10

26
63
33

4.3
2.1
3

4.90E-10
2.50E-08
2.70E-08

23
14
18
57
11
38

3.9
5.2
3.8
1.7
4.5
1.8

4.50E-08
1.10E-06
2.40E-06
4.40E-05
8.60E-05
6.90E-04
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1.6

9.30E-04

16

2.4

2.00E-03

MF
MF
MF
MF
MF
MF
MF
MF
MF
MF
MF
MF
MF
MF
MF
MF
MF
MF
MF
MF

transmembrane transporter activity
lysozyme activity
UDP-glycosyltransferase activity
metal ion binding
efflux transmembrane transporter activity
hydrolase activity, acting on ester bonds
transferase activity, transferring glycosyl
groups
RNA polymerase II transcription factor
activity, sequence-specific DNA binding
carboxylic ester hydrolase activity
ATPase activity, coupled to transmembrane
movement of substances
transcriptional activator activity, RNA
polymerase II core promoter proximal region
sequence-specific binding
heme transporter activity
ATPase activity
MAP kinase activity
stearoyl-CoA 9-desaturase activity
acid phosphatase activity
acyl-CoA dehydrogenase activity
acyl-CoA oxidase activity
oxidoreductase activity, acting on the CH-CH
group of donors, with a flavin as acceptor
DNA binding

18
5
7
132
4
8

2.3
7
4.3
1.2
9.3
3.1

2.30E-03
3.80E-03
4.50E-03
4.80E-03
6.10E-03
1.20E-02

20

1.8

1.60E-02

10
6

2.4
3.7

2.10E-02
2.10E-02

9

2.3

3.60E-02

4
3
13
4
3
6
5
3

5.1
8.4
1.8
4.3
7
2.7
3
6

3.90E-02
4.40E-02
5.10E-02
6.00E-02
6.30E-02
6.60E-02
7.70E-02
8.40E-02

5
68

2.9
1.2

8.70E-02
9.30E-02

Table 5.3: GO Term analysis of genes that changed in N2 strain under pathogenic
conditions (exposed to E. faecalis OG1RF) compared to non-pathogenic conditions
(exposed to E. coli OP50). BP: Biological Processes; MF: Molecular Functions. CC: Cellular
Component.
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hpx-2(dg047) on OP50 vs. hpx-2(dg047) on OG1RF
Category Term
Count Fold
Enrichment
BP
protein dephosphorylation
71
3.3
BP
peptidyl-tyrosine dephosphorylation
50
3.7
BP
innate immune response
83
2.2
BP
regulation of cell shape
39
3.3
BP
peptidyl-serine phosphorylation
38
2.4
BP
epithelial cell development
13
4.5
BP
metabolic process
175
1.4
BP
nonmotile primary cilium assembly
15
3.8
BP
protein phosphorylation
83
1.6
BP
peptidyl-tyrosine autophosphorylation
17
3.3
BP
molting cycle process
10
4.9
BP
homophilic cell adhesion via plasma
membrane adhesion molecules
9
5.3
BP
cell projection organization
10
4.6
BP
transmembrane receptor protein tyrosine
kinase signaling pathway
18
2.8
BP
cuticle development
10
4.4
BP
intraciliary transport
8
5.1
BP
single-organism transport
6
7.1
BP
oxidation-reduction process
87
1.4
BP
negative regulation of endopeptidase activity
16
2.4
BP
cell differentiation
36
1.7
BP
defense response
27
1.9
BP
cilium assembly
11
2.9
BP
flavonoid biosynthetic process
18
2.1
BP
flavonoid glucuronidation
18
2.1
BP
nematode male tail tip morphogenesis
19
2
BP
defense response to Gram-negative
bacterium
20
2
BP
detection of stimulus involved in sensory
perception
4
8.3
BP
sperm motility
4
8.3
BP
cell-matrix adhesion
5
5.2
BP
positive regulation of transcription from RNA
polymerase II promoter
31
1.6
BP
hyperosmotic response
8
2.9
BP
proteolysis
59
1.3
BP
carbohydrate metabolic process
29
1.5
BP
chemotaxis
14
2
BP
mesodermal cell migration
5
4.1
BP
dorsal/ventral axon guidance
7
2.9
BP
collagen and cuticulin-based cuticle
development
22
1.6
BP
dauer entry
12
2
BP
regulation of neuron differentiation
5
3.8
91

P-value
3.00E-21
1.70E-17
6.20E-12
1.10E-11
3.90E-07
6.00E-06
7.40E-06
1.10E-05
1.60E-05
2.00E-05
5.10E-05
6.70E-05
9.10E-05
9.80E-05
1.50E-04
3.20E-04
4.30E-04
1.40E-03
2.00E-03
2.20E-03
2.20E-03
2.50E-03
3.80E-03
3.80E-03
3.90E-03
4.50E-03
6.30E-03
6.30E-03
9.80E-03
1.00E-02
1.60E-02
2.00E-02
2.10E-02
2.10E-02
2.40E-02
2.60E-02
2.80E-02
2.90E-02
3.40E-02

BP
BP
BP
BP
BP
BP
BP
BP
BP
BP
BP
BP
BP
BP
BP
BP
BP
BP
BP
BP
BP
BP
BP
BP
BP
CC
CC
CC
CC
CC
CC
CC
CC
CC
CC
CC
CC
CC
CC
CC
CC
CC
CC
CC
CC
CC
CC

cell-cell signaling
fatty acid alpha-oxidation
defense response to Gram-positive bacterium
spermatid development
spermatogenesis
fatty acid metabolic process
3'-UTR-mediated mRNA destabilization
multicellular organism development
response to xenobiotic stimulus
protein localization to ciliary transition zone
regulation of backward locomotion
anterior/posterior pattern specification
chitin metabolic process
one-carbon metabolic process
lipid metabolic process
male meiosis chromosome segregation
Roundabout signaling pathway
cell fate specification involved in pattern
specification
regulation of axonogenesis
S-adenosylmethionine biosynthetic process
response to gamma radiation
peptidyl-tyrosine phosphorylation
response to stimulus
L-amino acid transport
oxygen transport
collagen trimer
extracellular region
membrane raft
extrinsic component of cytoplasmic side of
plasma membrane
intracellular membrane-bounded organelle
ciliary basal body
cilium
integral component of membrane
intraciliary transport particle B
membrane
neuron projection
axoneme
proteinaceous extracellular matrix
cell projection
nonmotile primary cilium
axonemal microtubule
motile cilium
BBSome
chromatin
cytoskeleton
dendrite
extracellular space
92

5
3
10
5
12
11
6
61
4
4
4
5
5
5
34
3
3

3.8
8.3
2.1
3.5
1.9
1.9
2.8
1.2
4.1
4.1
4.1
3.2
3.2
3.2
1.3
6.2
6.2

3.40E-02
4.00E-02
4.50E-02
4.70E-02
4.80E-02
5.00E-02
5.60E-02
5.70E-02
6.10E-02
6.10E-02
6.10E-02
6.10E-02
6.10E-02
6.10E-02
6.90E-02
7.40E-02
7.40E-02

3
3
3
4
10
5
5
6
64
84
23

6.2
6.2
6.2
3.7
1.8
2.8
2.8
2.4
3.1
2.1
2.7

7.40E-02
7.40E-02
7.40E-02
8.40E-02
8.50E-02
9.70E-02
9.70E-02
9.90E-02
6.60E-17
2.40E-11
2.30E-05

17
29
10
15
779
7
788
18
6
10
21
16
3
4
4
7
36
15
40

3.2
2.1
4
2.6
1.1
4.8
1.1
2
4.5
2.6
1.7
1.9
8.3
4.7
4.7
2.3
1.3
1.6
1.3

2.70E-05
2.10E-04
3.90E-04
1.10E-03
1.30E-03
1.50E-03
1.50E-03
5.90E-03
6.20E-03
1.10E-02
1.80E-02
2.00E-02
4.00E-02
4.20E-02
4.20E-02
7.10E-02
7.30E-02
7.40E-02
7.70E-02

MF
MF
MF
MF
MF
MF
MF
MF
MF
MF
MF
MF
MF
MF
MF
MF
MF
MF
MF
MF
MF
MF
MF
MF
MF
MF
MF
MF
MF
MF
MF
MF
MF
MF
MF

structural constituent of cuticle
protein tyrosine phosphatase activity
phosphoprotein phosphatase activity
receptor binding
heme binding
monooxygenase activity
iron ion binding
protein kinase activity
oxidoreductase activity, acting on paired
donors, with incorporation or reduction of
molecular oxygen
non-membrane spanning protein tyrosine
kinase activity
protein tyrosine kinase activity
hydrolase activity
steroid hydroxylase activity
serine-type endopeptidase inhibitor activity
oxidoreductase activity
metallopeptidase activity
transferase activity, transferring hexosyl
groups
protein serine/threonine kinase activity
Roundabout binding
transcriptional activator activity, RNA
polymerase II core promoter proximal region
sequence-specific binding
chitin binding
RNA polymerase II regulatory region
sequence-specific DNA binding
metalloendopeptidase activity
lysozyme activity
glucuronosyltransferase activity
transmembrane transporter activity
phytanoyl-CoA dioxygenase activity
structural constituent of collagen and
cuticulin-based cuticle
transporter activity
calcium ion binding
UDP-glycosyltransferase activity
oxidoreductase activity, acting on single
donors with incorporation of molecular
oxygen, incorporation of two atoms of oxygen
ATPase activity, coupled to transmembrane
movement of substances
methionine adenosyltransferase activity
acid phosphatase activity
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67
51
42
27
43
31
34
84

3.1
3.5
3.1
3.1
2.2
2.6
2.3
1.6

1.60E-18
7.20E-17
7.90E-12
8.90E-08
8.90E-07
1.20E-06
3.90E-06
7.10E-06

27

2.5

1.20E-05

19
26
133
14
16
75
30

3
2.5
1.3
2.9
2.6
1.4
1.8

1.60E-05
1.80E-05
5.30E-04
5.50E-04
6.30E-04
2.40E-03
2.70E-03

21
54
4

2
1.5
7.8

3.30E-03
4.20E-03
7.50E-03

6
13

4.3
2.2

8.00E-03
1.30E-02

20
23
5
15
22
3

1.7
1.6
3.9
1.8
1.5
7.8

2.20E-02
2.20E-02
2.90E-02
3.60E-02
4.40E-02
4.50E-02

7
21
34
7

2.5
1.5
1.4
2.4

5.20E-02
5.80E-02
6.00E-02
6.30E-02

4

3.9

7.10E-02

12
3
8

1.7
5.9
2

7.60E-02
8.20E-02
9.10E-02

Table 5.3: GO Term analysis of genes that changed in hpx-2 mutant strain under
pathogenic conditions (exposed to E. faecalis OG1RF) compared to non-pathogenic
conditions (exposed to E. coli OP50). BP: Biological Processes; MF: Molecular Functions.
CC: Cellular Component.
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Figure 5.3. Scatter plot of genes changed under pathogenic conditions, as compared to
non-pathogenic conditions, in either N2 strain (x-axis) or hpx-2 mutant (y-axis). Values of
10 or -10 indicate expression level under one condition was 0 RPKM.
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Discussion
In this chapter, RNASeq revealed that loss of hpx-2 modestly impacts the expression of
genes that are involved in cuticle generation, body morphogenesis, and immune defense
against pathogenic bacteria, indicating HPX-2 may be influencing these processes. This
observation is consistent with the weaker cuticle structure and increased susceptibility to
pathogens (Figure 3.12 and Figure 4.4).
Although the transcriptome changes detected in the worms were modest, both in the
number of genes affected and the amplitude of the effect, several observations suggest these
reflect the biological effect of HPX-2. First, hpx-2 gene expression is restricted to a few cells,
and thus we would not expect large transcriptome effects that are averaged over the whole
animal. Second, we performed five biological replicates of RNAseq and the differences were
highly reproducible. Third, the affected genes are enriched for cuticle biogenesis, which
correlates well with the known requirement for peroxidases in cuticle cross-linking. Fourth,
although the overlap in genes that were significantly affected in hpx-2 mutant under the two
conditions is modest, in most cases genes that were significantly affected in one direction under
the E. coli condition were affected in the same direction under the E. faecalis condition and vice
versa, even if the effect reached significance only in one comparison (Figure 5.3). Finally, I used
qRT-PCR to validate ten genes that were changed in the hpx-2 mutant compared to N2 under
pathogenic conditions. These qRT-PCR experiments were performed on RNA isolated from
three biological replicates that were independent of the RNAseq RNA samples, yet there was a
strong correlation between the results (Figure 5.1; R2=0.92 between fold change by RNAseq
and qRT-PCR). Therefore, I believe that there were modest but significant effects on the
transcriptome that implicate HPX-2 in cuticle biogenesis and defense against Gram-positive
bacteria.
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Through the RNAseq analysis, we were able to evaluate several subtle changes in
global transcription compared to the N2 strain. First, when worms were under non-pathogenic
conditions, no obvious physiological abnormalities was observed in the hpx-2 mutant. However,
a large number of genes involved in cuticle biogenesis were differentially expressed according
to RNAseq result, which explains the subtle increase in cuticle permeability phenotype observed
in the hpx-2 mutant. Secondly, genes that are involved in locomotion were differentially
expressed in the hpx-2 mutant under non-pathogenic conditions, suggesting a potential role for
HPX-2 in regulating this process. Indeed, when hpx-2 was overexpressed in the worm,
occasional dumpy and roller phenotypes were observed. Lastly, several components of the p38
MAPK pathway were slightly induced in hpx-2 mutant, consistent with the overall increase in the
innate response observed in the hpx-2 mutant.
When comparing the pathogenic condition with the non-pathogenic, it was not surprising
that a much larger set of genes were affected. Although the overall gene expression profile was
not that different between N2 and hpx-2 when exposed to pathogen, a much stronger response
was observed in the hpx-2 mutant, possibility due to the already disturbed physiological state in
hpx-2 mutant. The increased microbial load of E. faecalis in hpx-2 mutant could also explain
why the transcriptional response was stronger compared to N2. Interestingly, the hpx-2
transcript was not detectable in the N2 strain under non-pathogenic conditions, and was not
induced following pathogen exposure. This again, highlights the specific expression pattern and
tight regulation of hpx-2 (Table S3). Other genes encoding proteins involved in cuticle
development like mlt-7 are expressed at intervals corresponding to the larval molts (29), and
were not affected by the loss of HPX-2.
In conclusion, RNAseq analysis revealed an altered gene expression profile in hpx-2
mutant, consistent with a role in body morphogenesis, locomotion, and cuticle biogenesis. When
exposed to the pathogen E. faecalis, loss hpx-2 resulted a stronger immune response
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compared to N2 strain likely due to the more aggressive colonization by the pathogen that
occurs in this background.
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Chapter 6 Conclusions and Perspectives
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Summary
In this work, I characterized a putative peroxidase, HPX-2, for its immuno-protective role
in C. elegans against multiple pathogens. Based on the expression pattern of HPX-2 and the
tissue specific RNAi, I suspect HPX-2 functions in two major tissues, the pharynx and the
hypodermis, for its function in preventing infections.
In the pharynx, the HPX-2::GFP expression pattern revealed that HPX-2 is likely to be
expressed in the gland cells located at the distal bulb of the pharynx. Gland cells function in
secreting vesicles through the process into the pharyngeal lumen and aiding cuticle remodeling
during the developmental process. Accordingly, loss of HPX-2 resulted in increased
susceptibility to and intestinal colonization by the Gram-positive bacterium E. faecalis but not
Gram-negative P. aeruginosa. The protective role of HPX-2 only applies to Gram-positive
bacterial and fungal species, but not to Gram-negative bacteria, suggesting the thick outer layer
of these pathogens could be the reason for this phenotype.
In terms of hypodermis function, I first showed that tissue-specific knock down of HPX-2
in the hypodermis significantly increased the susceptibility of worms to E. faecalis. Loss of HPX2 also resulted in a less intact cuticle as measured by a permeable DNA dye, suggesting again
the role of HPX-2 in pathogen resistance is a function of cuticle reinforcement.
Finally, I utilized RNAseq analysis as an un-biased and highly sensitive measurement of
global transcriptomic changes upon the loss of HPX-2. The RNAseq results provided insight into
the potential physiological processes HPX-2 is involved in. Under non-pathogenic conditions,
loss of hpx-2 resulted in a subtle but significant change in genes involved in cuticle biogenesis,
locomotion, and molting, confirming the role of HPX-2 in cuticle biogenesis during development.
Under pathogenic conditions, in addition to the enrichment of cuticle genes, there was
significant induction of genes involved in innate immunity, suggesting a stronger immune
response compared to N2 strain. Surprisingly, the expression level of hpx-2 is extremely low on
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the organismal level resulting in hpx-2 gene reads being undetectable through RNAseq.
However, the fact that loss of HPX-2 still results in dramatically increased sensitivity to the
pathogen E. faecalis highlights its importance in innate immunity.
In conclusion, I showed that HPX-2 is expressed in the pharynx and hypodermis of the
worm strengthening the cuticle lining these organs and resulting in less colonization and
multiplication of the pathogen in the intestine.
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Discussions and future directions
Cuticle reinforcement role of HPX-2
Cuticle is the very outside layer that covers the worm body, and functions in protecting
the worm from environmental insult, supporting the body structure, and facilitating locomotion
through attachment with the underlying muscles (151-153). The body cuticle is secreted by the
underlying hypodermal cells and has distinct layers and structures. The very outside layer of
body cuticle is the surface coat majorly consisting of glycoproteins, whereas the remaining four
layers underneath contain cross-linked collagens and cutlins proteins (30). So far, a wide range
of cuticle defective mutants have been identified and studied, which cause a variety of
phenotypes, from altered body morphology, abnormal surface appearance, to pathogen
resistance (30).
In addition to the worm body, the four major openings of the worm (pharynx, vulva, anus,
and excretory pore) are also covered with cuticle. However, unlike the body cuticle, openinglining cuticle lacks complex layers, and is mainly composed of soluble collagen proteins and
insoluble cutlin proteins (30).
As the major component of the cuticle, collagen proteins encompass up to 80% of the
soluble proteins in the extracellular matrix. The C. elegans genome encodes for over 170
collagen proteins (30). Thus far, 21 collagen-encoding genes have been shown to be involved in
worm morphology (30). Mutation of these genes results in a variety of phenotypes including
Dumpy (Dpy), Roller (rol), Blister (bli), and Squat (Sqt). Surprisingly, 10 out of those 21 genes
were significantly altered in hpx-2 mutant according to the RNAseq analysis, providing a strong
indication that the loss of HPX-2 affects the overall cuticle structure and morphology of the
worm. However, like the other genes that were differentially expressed in the hpx-2 mutant, the
log2 fold-changes were not dramatic, most of them falling between one and two, suggesting a
102

subtle change. This could also explain why there were no visible morphology defects; only the
Hoescht dye assay indicated a small disturbance in cuticle integrity (See chapter 4 for more
detail).
The cuticle is also the site of first contact between the worms and some pathogenic
microbes that rely on the attachment and penetration of worm’s surface for their pathogenicity.
Some components of the cuticle such as the carbohydrate-rich surface coat serve as a
protective shield from pathogen attachment, and mutations in genes that are involved in
production and secretion of these components result in increased pathogen susceptibility (50,
154). For example, loss of function mutations in bacterially Un-Swollen genes bus-2, bus-4, bus12, and bus-17 increases attachment of the fungal pathogen Drechmeria coniospora spores to
the cuticle (155), Microbacterium nematophilum to the rectal epithelia (156-159) and Yersinia
pseudotuberculosis to the head (160, 161). For the pathogens tested in this study, the site of
infection was the intestine. It would be interesting to test the susceptibility of the hpx-2 mutant to
cuticle pathogens, and such an investigation might provide more insight into HPX-2’s function in
hypodermal immunity.
While the body cuticle serves as the very first line of defense against environmental and
microbial insult, the pharynx, especially the grinder, has a similar function against potential
pathogens that are ingested. Studies have shown that mutants that have defective grinding
function had increased uptake of intact microbes, resulting in higher susceptibility to pathogens
(71, 162).
In terms of the pharyngeal function of HPX-2, it is very likely that it plays the same role in
hypodermis, specifically cuticle cross-linking, since the pharyngeal lumen including the grinder
is lined with cuticle and it is connected to the cuticle of the hypodermis (30). By physical
strengthening of the pharyngeal grinder, HPX-2 functions in pathogen resistance. Alternatively,
HPX-2 could serve as a secreted peroxidase in the gland cells located in the distal bulb of the
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pharynx for cuticle grinder strengthening or aiding digestion of the microbe. While the cell body
of the gland cells are embedded within the muscle cell epithelium at the distal bulb of the
pharynx, there are structures, named processes, that protrude from the cell body and open into
the pharyngeal lumen (135). During the molting process, the gland cells excrete vesicles that
contains enzymes that aid in the tearing down of the old cuticle lining inside the pharynx and
around the worm body (135, 136). When feeding on bacteria, a different kind of vesicle is
secreted to aid in digesting food (135). In chapter 4, I showed that the expression of HPX2::GFP in pharynx, specifically, the expression pattern resemble the gland cells in the pharynx
in dauer worms and occasionally a protruding structure extending from the posterior bulb to the
buccal cavity of the worms. It could be that HPX-2 is being produced in the gland cells located
at the distal bulb and being secreted during molting and/or feeding.
To further investigate whether HPX-2 is functioning in the physical reinforcement of the
pharyngeal grinder or chemically aiding the digestion of microbes, it would be interesting to feed
the worms with fluorescently-labeled beads that would normally be disrupted by a healthy
grinder. If the intestinal fluorescence is stronger in hpx-2 mutant compared to N2 strain, it would
indicate a less intact grinder in HPX-2 mutant. Alternatively, we could cross hpx-2 lines with
those with known pharyngeal defects, i.e. the eat mutants, to see if there is an additive affect in
pathogen susceptibility.

The peroxidase activity of HPX-2
In order to understand the mechanism of protection of HPX-2 in innate immunity, it is
crucial to understand its enzymatic activity as a heme-peroxidase, specifically, the ability to
utilize H2O2 as a substrate to carry out oxidation reactions. I first utilized Amplex Red Assay as a
measurement for the level of H2O2 during infection. Previous studies showed that when exposed
to pathogen, C. elegans produces elevated level of H2O2, and the deletion of a major
104

peroxidase could further increase H2O2 level (99, 102). However, the Amplex Red Assay did not
reveal an increased level of H2O2 in hpx-2 mutants when exposed to pathogen, suggesting
HPX-2 is not a major consumer of H2O2 (Figure 4.8). On the other hand, the immune protective
peroxidase previously identified in our lab, SKPO-1, was demonstrated to utilize H2O2 when
worms where exposed to pathogen, because the level of H2O2 drastically increases in the skpo1 mutant. There are a couple of possible explanations for the fact that I did not detect changes
in the H2O2 levels in the hpx-2 mutant. It could be because HPX-2 possesses little peroxidase
activity under the conditions tested. It also could be due to low levels of HPX-2 such that the
Amplex Red Assay was not sensitive enough to detect a change. Also, along the same line of
reasoning, the fact that SKPO-1 is a major consumer of H2O2 during infection could mask the
contribution of HPX-2’s peroxidase activity. Last but not least, it’s likely that HPX-2 role
happens early during development and it is not active in the adult animal.
To test whether HPX-2’s peroxidase activity is required for pathogen resistance, a point
mutation was generated in the hpx-2 gene through CRIPSR-cas9 mediated mutagenesis.
Specifically, the catalytic arginine residue that is highly conserved throughout peroxidasecyclooxygenase superfamily was substituted with Alanine in HPX-2, resulting in a mutant protein
in which peroxidase activity is expected to be lost (141, 163). Worms harboring the mutated
version of HPX-2 exhibited increased susceptibility to pathogens (Figure 4. 9), indicating the
peroxidase activity is required for HPX-2’ s immune protective role (see Chapter 4 for more
detail)
The natural next step in exploring the activity of HPX-2 is through in-vitro purification and
enzymatic analysis of the protein. Historically, using a baculovirus system in eukaryotic cells,
multiple human peroxidases including MPO and LPO have been expressed (139). On the other
hand, some studies showed that the peroxidase domain-containing proteins BLI-3 and MLT-7
can be expressed and purified from an E. coli expression system with the peroxidase activity
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intact (28), (29). Given the lack of expertise in viral-mediated protein expression, I decided to
try the E. coli expression system first. Unfortunately, my attempt at purifying the recombinant
HPX-2 was not successful. One explanation for lack of good expression could be the
differences in codon preference in E. coli versus C. elegans. To address this problem, we could
order artificially synthesized, codon-optimized DNA, encoding HPX-2. Another potential problem
with using the E. coli system is that peroxidases are usually heavily glycosylated during the
post-translational process, and the modifications can be crucial for their full activity. In that case,
a eukaryotic expression system may be the better choice for the expression and purification of
fully active peroxidase.

Potential involvement of HPX-2 in innate immune pathways
Given the cuticle reinforcement function and potential peroxidase activity of HPX-2, there
might be two non-mutually exclusive ways HPX-2 is involved in innate immunity. The first
possibility is through the disturbed hypodermis and downstream signal pathway to activate the
immune effectors. One example of this is the activation of AMP genes by the disruption of the
hypodermis. Specifically, disruption of the hypodermis by fungal pathogen or in dpy-9 and dpy10 mutants results in an increased level of a tyrosine derivative 4-hydrophenyllactic acid
(HPLA), which then activates its cognate G protein-coupled receptor (GPCR) DCAR-1 (84). The
activation of DCAR-1 then triggers the expression of AMPs through p38 MAPK pathway and via
the release of a negative regulator STA-2 (84, 164). Another example is from a recent study
showing that disruption of specific structures of the cuticle triggers the activation of multiple
stress response and innate immunity pathways (148). Specifically, disruption of the annular
furrows by knocking down dpy-2, dpy-3, dpy-7, and dyp-10 genes activates detoxification,
osmolyte resistance, and most importantly, antimicrobial responses in C. elegans (148). It was
also discovered that multiple transcription factors act downstream of this process with
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overlapping functions: i.e SKN-1/Nrf and ELT-3/GATA for detoxification, STA-2/stat and ELT3/GATA for antimicrobial gene expression (148).
Intriguingly, one important observation from the RNAseq analysis is that the key player
in the p38 MAPK, pmk-1, was induced upon the loss of HPX-2 under non-pathogenic
conditions. In addition to pmk-1, genes that encode for the other two MAPK kinases, pmk-2 and
pmk-3, were also upregulated 2 to 6-fold in the hpx-2 mutant compared to the N2 reference
strain under the same conditions. This suggests that loss of HPX-2 had subtle but significant
effects on the major immune signaling pathway. However, the physiological relevance of this
effect requires further investigation.
The other possible role for HPX-2 in innate immunity that I explored is production of an
immune effector for pathogen elimination, in this case, a strong oxidant that could be derived
from an oxidation reaction using H2O2 as a substrate. As discussed in section 6.1 of this
chapter, HPX-2 pharyngeal localization and the requirement of its catalytic residue for pathogen
resistance indicate that HPX-2 might be serving as a catalytic enzyme aiding the digestion/
elimination of ingested pathogens. One way to further test this hypothesis is to purify HPX-2 and
assay for its enzymatic activity against different substrates.

Interactions with BLI-3
To explore the possibility of physical interactions between BLI-3 and HPX-2, I first tried
the yeast-two-hybrid method, in which I cloned the full-length HPX-2 and the peroxidase domain
of BLI-3 into the yeast two hybrid vectors. However, I was not able to detect any interaction
between BLI-3/SKPO-1 and BLI-3/HPX-2 (Figure 6.1 A and B). I reasoned that since BLI-3 and
the peroxidases all have a predicted secretion signal peptide at their N terminus, they could be
excreted out from yeast cells during production, contributing to a lack of detectable interactions.
Hence, I cloned those genes without the signal peptide sequence into the yeast 2-hybrid
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plasmids and tested their interactions. However, there was still no interaction detected (Figure
6.1 C). it could be that DUOXs are usually extensively glycosylated during protein synthesis
and such modifications are critical for their cell surface expression activity such that the yeast 2hybrid system is not suitable (140). An alternative assay that could be used to explore this
question further and has the advantage of being in vivo is the bimolecular fluorescence
complementation (Bi-FC) assay (165). Specifically, the BLI-3 peroxidase domain and its
potential interacting peroxidases could be fused to two non-fluorescent fragments derived from
a fluorescent protein. The constructs would then be delivered into C. elegans through
microinjection. Fluorescent signals can be detected if there is an interaction between BLI-3 and
the peroxidases. Last but not least, co-immunoprecipitation (co-IP) could be applied to
investigate direct interaction between BLI-3 and HPX-2. It has been previously demonstrated
that the peroxidase domain of hDUOX1 may mediate protein-protein interaction through its
cysteine residues (166). Given its significant sequence homology with BLI-3, it is postulated the
protein-protein interaction function of hDUOX1 might be conserved in BLI-3. A potential problem
with this approach is that the extremely low expression of HPX-2 on the whole organism level
will make the detection of an IP-ed product difficult.
Although it is postulated that there might be direct interactions between BLI-3 and H2O2
utilizing peroxidases, it could also be that direct physical interaction is not required for the
function of peroxidases for the following reasons: First, H2O2 is a diffusible molecule that moves
freely intracellularly and extracellularly following the concentration gradient. This makes H2O2
easily accessible to peroxidases in proximity. Second, although BLI-3 is a membrane anchored
protein, many peroxidases are secreted. Through temporal and spatial control of the
peroxidases, a close proximity could be created between the two.
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A
-Leu, -Trp

-Leu, -Trp, -His

1175/1174
pOAD/pOBD-SKPO-1
pOAD/pOBD-BLI-3
pOBD/pOAD-SKPO-1
pOBD/pOAD-BLI-3
pOAD-SKPO-1/pOBD-BLI-3
pOAD-BLI-3/pOBD-SKPO-1

B

-Leu, -Trp

-Leu, -Trp, -His

-Leu, -Trp

-Leu, -Trp, -His

1175/1174
pOAD/pOBD-F09F3.5
pOAD/pOBD-BLI-3
pOBD/pOAD-F09F3.5
pOBD/pOAD-BLI-3
pOAD-F09F3.5/pOBD-BLI-3
pOAD-BLI-3/pOBD-F09F3.5

C

1175/1174
pOBD-SKPO1’/pOAD-BLI-3
pOAD-P1’/pOBD-BLI-3

Figure 6.1 No interaction between BLI-3 and the two peroxidases (HPX-2 and SKPO-1) is
detected by Yeast-2-hybrid.
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